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ABSTRACT 
 
 
JOCELYN BRINEMAN SWEENEY. A theory-based evaluation of an intervention for 
HPV risk reduction among college-aged women. (Under the direction of DR. RICHARD 
D. MCANULTY and DR. CHARLIE L. REEVE) 
 
 
The goal of the study was to examine the effectiveness of a group intervention in 
reducing risk in relation to human papillomavirus (HPV) among sexually active, college-
aged women.  Using a randomized design, the current study examined the effectiveness 
of an HPV educational group intervention guided by previous sexual risk-reduction 
research and the Theory of Planned Behavior (TPB; Ajzen, 1991).  The intervention was 
provided in a standard, in-person group format consisting of a single session.  Measures 
were completed prior to the intervention, immediately after the intervention, and one 
month post-intervention (Fisher, 1997). Consistent with TPB (Ajzen, 2002), study 
outcomes included predicted changes in the following: 1) HPV knowledge, 2) attitudes 
towards risk-reduction behaviors (e.g., reducing new sexual partners, using barrier 
contraceptives, discussing STIs with partners, receiving HPV vaccine, seeking 
information on HPV, receiving a Pap smear, getting tested for HIV and other STIs), 3) 
subjective norms in association with the risk-reduction behaviors, 4) perceived behavioral 
control of the risk-reduction behaviors, 5) intention to perform the risk-reduction 
behaviors, and 6) the actual risk-reduction behaviors.  Consistent with the hypotheses, the 
intervention was successful at increasing knowledge, behavioral intentions, HPV 
information-seeking and HIV testing and these changes were maintained over a one-
month interval.  Modest increases in attitudes toward risk-reduction behaviors, subjective 
norms, and perceived behavioral control were obtained immediately after the 
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intervention, but not at follow-up. Contrary to the hypothesized outcome, the intervention 
was also not successful at creating increases in social norms and many of the risk 
reduction behaviors (e.g., reducing new sexual partners, using barrier contraceptives, 
discussing STIs with partners, receiving HPV vaccine, receiving a Pap smear, getting 
tested for STIs).  These findings do provide some empirical support for a brief one-time 
educational intervention in reducing the risk of an HPV infection.   
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CHAPTER 1: INTRODUCTION  
 
 
Since 1913, the control and prevention of sexually transmitted infections (STIs) 
has been a significant focus of public health officials in the United States (U.S.) and a 
common area of emphasis in health promotion programs (McGough & Handsfield, 
2007).  However, it was not until the 1980s that behavioral interventions became 
common practice (McGough & Handsfield, 2007).  The goal of such health promotion 
programs, also referred to as risk reduction, is to diminish the risk of infection among 
populations considered to be at-risk as indicated by prevalence and incidence rates  
(Bennett & Hodgson, 1992).  Typically, the interventions aim to reduce risk behaviors 
and increase risk-reduction behaviors (St. Lawrence & Fortenberry, 2007).   
When determining at-risk populations, a primary method is to examine the rate of 
new infections among various populations.  With regard to STIs, researchers have 
consistently demonstrated that adolescents and young adults have disproportionately high 
rates of STIs (Ethier & Orr, 2007).  In fact, over half of all new STI infections are 
attributed to persons aged 15-24 (Centers for Disease Control [CDC], 2012e; Weinstock, 
Berman, & Cates, 2004).   
          There are many known behavioral risk factors for STIs among adolescents, 
including intercourse with multiple partners, intercourse with a sexual partner who has 
had multiple partners, first intercourse at an early age, infrequent condom use, lack of 
STI testing, and a history of STIs (CDC, 2010b; Daley et al., 2008; Denny-Smith, Bairan, 
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& Page, 2006).  In the U.S., young adults tend to engage in multiple, brief monogamous 
relationships (Herbenick et al., 2010). Because these sequential relationships are 
relatively exclusive, these individuals consistently underestimate their risk of STI 
exposure while engaging in unprotected sexual intercourse with a number of individuals. 
Currently, over half the rate of new STIs occur in older adolescents even though they 
only account for 25% of the sexually active population (CDC 2010c).  Results from a 
national study indicate that the rate of older adolescent STIs is growing rapidly and 
surpassing other age groups in STI infection rates (CDC, 2010c).  The highest rate of 
growth is seen among young women (CDC, 2011) attributable, in part, to greater cervical 
ectopy in younger women (CDC, 2012e).  Therefore, STI risk-reduction programs aimed 
at young women remain critically important (Hiltabiddle, 1996).    
Human Papillomavirus  
Human papillomavirus (HPV) is a virus that is spread through skin-to-skin 
contact, particularly genital contact.  Given the ease of transmission and the inability of 
current barrier contraceptive methods (e.g., male condoms, dental dams, female 
condoms) to completely prevent transmission, HPV is the most common STI in the U.S. 
and is estimated to infect approximately 6.2 million individuals annually (CDC, 2010b).  
In fact, approximately 20 million Americans are currently infected (CDC, 2012a) and it 
has been reported that its lifetime prevalence in the U.S. is over 50% (CDC, 2010b). This 
is of particular concern given the known causal link between HPV and a number of 
problems, including anxiety, relationship distress (Ferris et al., 2008), genital warts and 
various cancers (CDC, 2010b; Parkin & Bray, 2006).  Women are disproportionately 
impacted by HPV-related cancers.  For example, cervical cancer affects over eleven 
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thousand women annually and results in over 4,000 deaths per year in the U.S. alone, 
making it one of the most common cancers among women (CDC, 2009a).   The annual 
incidence rate of HPV-associated anal cancer among women is 2,700 compared to 1,500 
among men.  Approximately 1,500 women are diagnosed with HPV-associated vulvar 
cancer each year and another 500 women are diagnosed with HPV-associated vaginal 
cancer (CDC, 2012a).   
While overall lifetime prevalence rates are high, research has demonstrated that 
certain factors are associated with elevated risks of infection with HPV.  Specifically, 
HPV-risk behaviors include intercourse with multiple partners, intercourse with a sexual 
partner who has had multiple partners, first intercourse at an early age, infrequent 
condom use and lack of STI testing, a history of STIs (CDC, 2010b; Daley et al., 2008; 
Denny-Smith et al., 2006) and cigarette smoking (Koutsky, 1997; Vail-Smith & White, 
1992).  Further, it has been suggested that younger individuals, aged 15-24 are among the 
highest risk populations for HPV infection in the U.S. (CDC, 2012c) with an incidence 
rate of 4.6 million and prevalence rate as high as 9.2 million (Weinstock et al., 2004).  
The financial impact of HPV among this age group is more than the cost of genital herpes 
and hepatitis B combined and equal to the cost of HIV (Steben & Duarte-Franco, 2008).  
According to researchers (Dell et al., 2000; Ingledue, Cottrell, & Bernard, 2004; Lambert, 
2001; Vail-Smith & White, 1992), the college student population (late teens to early 20s) 
is at an even higher risk (CDC, 2012d), accounting for approximately 74% of the HPV 
infections in the U.S. (CDC, 2009b), which is often attributed to the abundance of 
potential partners and associated sexual risk behavior (Burak & Meyer, 1997; Denny-
Smith et al., 2006; D’Urso, Thompson-Robinson, & Chandler, 2007; Lopez & McMahan, 
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2007).  This is especially relevant to women, as indicated by incidence rates of HPV 
among college women ranging from 43 to 60% (Fernández-Esquer, Ross, & Torres, 
2000)  and infection rates as high as 45% among women aged 20-24 (Dunne et al., 2007), 
making it the most common STI among young women (Forhan et al., 2008).   Therefore, 
when discussing risk factors for HPV infection, a necessary category of risk to examine 
includes a wide variety of social, biological, and environmental factors.   
HPV Vaccine 
Currently, there are two vaccines available for use among women (Gardasil® and 
Cervarix®).  Gardasil®, a quadrivalent vaccine that is licensed for use among women 
and men age 9-26, protects against two types of HPV known to cause cervical cancer (16, 
18) along with two HPV types that cause genital warts (6 and 11) (CDC, 2012c; Liddon, 
Zimet, & Stanberry, 2007).  Cervarix® is a bivalent vaccine licensed only for women age 
10-25 (CDC, 2012c) that protects against types 16 and 18.  Both vaccines are delivered in 
a 3-dose series and recommended prior to the onset of sexual activity (for a review of 
HPV vaccines see www.cdc.gov/std/hpv/monitoring-rpt.htm).  Research indicates that, 
despite the availability of the vaccines, current rates of vaccination are surprisingly low.  
In a sample of 409 women aged 13-26, 5% had started the vaccination series (Kahn et al., 
2008) and only .2% had completed the entire series of three (Kahn et al., 2008).  In a 
sample of 1,401 college women, the completed rate of vaccination was 14% (Allen et al., 
2009), indicating that a significant portion of the higher risk population is not receiving 
the vaccine, possibly due to  perceived barriers to vaccination (e.g., cost and side-effects) 
(Conroy et al., 2009; Zimet, Weiss, Rosenthal, Good, & Vichnin, 2010). For example, the 
vaccine is delivered in a 3-dose series.  The second dose must be received within 1-2 
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months of dose 1 while the third dose must be received within 6 months of dose 1 (CDC, 
2012d).   Additional barriers have included time constraints, availability, and access to 
low-income populations (Kahn et al., 2008). Moreover, given the high incidence rates of 
HPV, a person may already be infected with one of the 4 types of HPV that the vaccine 
was designed to prevent.  Although it is highly unlikely they are infected with all four 
and therefore, will still receive some protection from the vaccine (Garland et al., 2007), 
they are not fully protected.  Further, while the vaccine is effective in preventing two 
types of cancer-related HPV (types 16 and 18) it does not protect against all types of 
cancer-causing HPV (CDC, 2012d).  For example, neither vaccine protects against the 
remaining 12 high-risk types which are associated with cervical lesions and anogenital 
(e.g., cervical) cancers.  Thus, the rate of non-vaccinated women who are at-risk for 
infection in conjunction with the rate of females who are already infected and the 
additional high-risk HPV types not prevented with the vaccine makes it necessary to 
examine additional feasible methods of risk reduction for women while concurrently 
promoting the HPV vaccination (Daley et al., 2008).   
A general lack of knowledge regarding sexual risk behaviors and risk-reduction 
methods increases risk for HPV (Dell et al., 2000; Lambert, 2001; Vail-Smith & White, 
1992; Yacobi, Tennant, Ferrante, Pal, & Roetzheim, 1999).  Although the FDA’s 
approval in 2006, of a vaccine (Gardasil®) to prevent four types of HPV for women ages 
9-26 resulted in a surge of information about HPV (Daley et al., 2008), several studies 
revealed that most individuals had very little knowledge about HPV prior to the 
Gardasil® media campaign led by Merck (Dell et al., 2000; Denny-Smith et al., 2006; 
Lambert, 2001; Yacobi et al., 1999).  In fact, Vail-Smith and White (1992) found that 
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only 13% of their sample of 323 participants had heard of HPV.  While an increase in 
knowledge has occurred since the release of the vaccine, (Daley et al., 2008; Gerend & 
Magliore, 2008; Lopez & McMahan, 2007), there are still large gaps in the level of 
knowledge, and many young adults remain uninformed (Lopez & McMahan, 2007).   
Only one-third of the 351 college students surveyed by D’Urso and colleagues (2007) 
were aware of HPV. In a study conducted by Gerend and Magloire (2008), 75% of their 
sample of 124 university students had heard of HPV and a significant portion 
demonstrated a clear understanding of the link between HPV and cervical cancer; 
however, only 45% of respondents perceived themselves to be at risk of being infected 
with HPV.   Similarly, 76% of women in a study conducted by Pitts and colleagues 
(2010) were aware that HPV causes cervical cancer, but only 44% were aware of how 
HPV is transmitted.  Therefore, while gains have been made in terms of awareness of 
HPV since the release of Gardasil®, many individuals are still demonstrating insufficient 
levels of knowledge regarding transmission and impact of an HPV infection.  Many 
young adults remain unaware of this health threat and associated risk factors which, in 
turn detracts from risk reduction.   
One main reason behind the problems with accurately estimating HPV exposure 
risks is a lack of knowledge regarding the behaviors that place them at risk (e.g., 
avoidance of testing, sex with multiple partners) and the ease in which HPV is 
transmitted (Lambert, 2001). Therefore, these individuals are at an increased risk for the 
consequences of infection (e.g., cervical cancer) because they are unaware of their 
infection and subsequently are unlikely to seek treatment, and they remain at risk of 
spreading the infection to sexual partners.  Research has shown that individuals often lack 
7 
 
understanding of, or have negative attitudes toward, HPV testing.  For example, in a 
qualitative study conducted by McCaffery and colleagues (2003), a majority of women 
reported a fear of testing due to the stigma associated with HPV. Dell and colleagues 
(2000) also found that understanding of testing methods was low (for a review of HPV 
testing methods see www.cdc.gov/std/hpv/pap/default.htm).  An additional reason for the 
reluctance to being tested seems to be that many individuals grossly underestimate their 
risk of infection. At- risk groups, including those who initiate intercourse at an early age 
and those with multiple sexual partners, consistently underestimate the likelihood that 
they have been exposed to HPV (Burak & Meyer, 1997; Dell et al., 2000; Ferris et al., 
2008).  
Given the widespread lack of knowledge and misinformation about HPV, it is not 
surprising that many individuals are unaware of risks and related factors (Vail-Smith & 
White, 1992; Yacobi et al., 1999).  Dell and colleagues (2000) found that only 35% of 
sexually active participants considered themselves at risk, indicating that a significant 
number of young adults are actually underestimating their risk despite the fact that they 
are engaging in the number one high risk sexual behavior associated with infection:  sex.  
HPV Risk Reduction Interventions 
Current research examining the impact of HPV risk reduction interventions has 
focused on vaccine acceptability and use (Chapman et al., 2010; Cox, Cox, Sturm, & 
Zimet, 2010; Reiter, Stubbs, Panozzo, Whitesell, & Brewer, 2011) or HPV-knowledge 
(Lambert, 2001).  For example, Chapman et al. (2010) examined the impact of an 
educational video to increase acceptability of the HPV vaccine.  Prior to watching the 
video, participants completed a 32-item survey to gather demographic information, HPV 
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knowledge and beliefs, and attitudes towards the HPV vaccine.  The video included 
information about HPV, including prevalence and transmission, along with information 
about the vaccine.  After watching the video, participants completed an 11-item survey.  
A total of 186 women between the ages of 18 and 60 completed pre-test, media 
intervention, and post-test.  The results indicated that vaccine acceptability increased 
from 66.7% prior to the video to 78% after watching the video.  The authors did not 
assess improvements in knowledge about HPV and no comparison group was used to 
determine the effectiveness of this intervention modality over others.  
Lambert (2001) conducted a study examining the impact of an educational 
intervention on the knowledge of HPV.  A total of 60 undergraduate students, a 
combination of two classes, were given a 12-item measure assessing their knowledge of 
HPV and other STIs.  One class was designated the control class while the other was 
assigned to the intervention condition.  Following completion of the measure, the 
intervention group received a brief, single HPV information-session (e.g., prevalence, 
association with cervical cancer).  Three months after the intervention, all students in 
both conditions completed 9-item follow-up measure to assess knowledge retention.  
Across both groups, knowledge on pre-test measures was lower for HPV than other STIs, 
with the highest amount of knowledge found for HIV.  Following the intervention, 
knowledge regarding HPV was highest in the intervention group suggesting that the 
educational intervention was effective and produced relatively long-term effects 
(Lambert, 2001).  However, given the lack of assessment of sexual behaviors, no 
information is available regarding the impact of the intervention on actual risk reduction.   
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Given the minimal amount of research examining the impact of HPV 
interventions on behavior change aside from vaccine use, it is useful to examine 
intervention efforts in other related fields to gain information about potential strategies.  
A number of STI risk-reduction interventions have shown great promise. 
Group Interventions 
Group interventions are the most common method of intervention used for STI 
risk reduction in the U.S. (St. Lawrence & Fortenberry, 2007) because they can be 
delivered to multiple participants, at a fraction of the cost and time of individual 
interventions (Gift & Marrazzo, 2007).  Additionally, in open group formats, individuals 
benefit from other group members’ inquiries, thereby furthering the depth or richness of 
the information they receive (McCree, Eke, & Williams, 2007).  According to Babouri 
(1985), group interventions can efficiently convey factual information while challenging 
the group members to integrate the information into their own “value systems” (p. 328).  
A review of STI interventions by Neumann and colleagues (2002) indicated that group 
interventions have been shown to be more effective than individual interventions in 
reducing sexual risk behaviors such as increased condom use and a decrease in the 
number of new sexual partners.   
According to St. Lawrence and Fortenberry (2007), interventions should be 
comprehensive and “provide information, encourage abstinence, promote condom use for 
those who are sexually active, encourage fewer sexual partners, and transmit sexual 
communication skills” (p.44).  A considerable body of research examining the efficacy of 
group STI risk-reduction interventions has focused primarily on HIV risk reduction 
(Shepherd, Peersman, Weston, & Napuli, 2000).  A number of these studies have yielded 
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promising results (DiClemente, Salazar, & Crosby, 2007; Jemmott & Jemott, 2000; 
Wingood & DiClemente, 1996), especially in behavioral outcomes such as condom use 
(Robin et al., 2004) which is a primary goal of HIV interventions.  For example, Jemmott 
and Jemmott (2000) reviewed 36 interventions focusing on risk reduction for HIV, six of 
which took place on college campuses.  Almost all of the studies included a follow-up 
that was conducted 6-months or less following treatment completion.  Based on the 
results of this review, the researchers determined that theory-based, group interventions 
were effective at increasing HIV knowledge and self-efficacy for behavior change while 
also reducing sexual risk behaviors.   
In another review article by Wingood and DiClemente (1996), the researchers 
concluded that interventions that combined a skills component (e.g., risk-reduction 
methods and proper condom use) and an information component (e.g., transmission and 
sexual risk behaviors) were more effective than interventions that contained information 
only, indicating that interactive and comprehensive interventions are most effective.  For 
example, Farrell and colleagues (2008) found that a risk-reduction group intervention for 
college students which focused on a combination of cognitive and behavioral skills to 
increase risk-reduction self-efficacy was effective in significantly increasing participants’ 
risk-reduction behaviors such as discussing STI testing and history with sexual partners 
along with purchasing and using condoms.  At follow-ups (1 and 2-4 months), 
participants maintained an increased knowledge of risk factors and general facts about 
HIV, an established mediator of risk reduction (Jemmott & Jemmott, 2000).   
In a similar study, Belden and colleagues (2008) evaluated an AIDS risk-
reduction intervention targeted at higher-risk teens aged 12-16 years.  The intervention 
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consisted of three 90-minute sessions focusing on strengthening self-efficacy with 
regards to sexual decision-making, effective communication with partners, and condom 
use.  Additionally, information about HIV/AIDS risk reduction was provided.  Although 
the results indicated that knowledge gain and self-efficacy were higher one month post-
treatment, instances of unprotected sex did not differ between the treatment and control 
groups, suggesting that self-efficacy interventions alone may not be sufficient in 
changing sexual risk behavior.    
Bryan et al. (1996) conducted a study examining the impact of a single-session 
intervention focusing on condom use among women.  The intervention group received a 
45-minute presentation focusing on safer sex consisting of video segments, lecture, 
discussion, and skill building.  All participants completed pre-test and immediate post-
test measures along with follow-up measures at 6-weeks and 6-months post-intervention.  
As the authors had predicted, the intervention group demonstrated increased intentions to 
use condoms immediately following the intervention compared to their pre-test 
intentions.  Further, their reported condom use had significantly increased at both the 6-
week and 6-month follow-ups, demonstrating the long-term impact of a single-session 
group.  
HPV and Theory:  The Theory of Planned Behavior 
Dworkin and colleagues (2006) recommended that successful interventions 
should be theoretically-based and gender specific.  Additionally, STI risk-reduction 
interventions for women should incorporate additional methods of protected sex beyond 
male condom use.  They noted that women should be empowered with options such as 
“outer course, female condoms, refusal, and leaving a sexual encounter or relationship 
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that was not amenable to safe sex negotiations” (Dworkin, Exner, Melendez, Hoffman, & 
Erhhardt, 2006, p. 43).   
A number of behavioral theories in the field of STI risk-reduction research 
maintain that in order for a person to engage in certain risk-reduction measures, she must 
possess the beliefs that will encourage her to do so.  Unfortunately, individuals who 
inaccurately perceive degree of risk for HPV are less likely to avoid sexual risk behaviors 
or engage in preventive behaviors, resulting in a higher risk of infection (Ingledue et al., 
2004).  Therefore, interventions targeting a change in the inaccurate beliefs and their 
influence on actions are necessary in order to prevent HPV infection.  Current STI 
interventions often rely solely on providing information about the infections with the goal 
of reducing risk through increased knowledge alone (St. Lawrence & Fortenberry, 2007).  
Researchers agree that knowledge of a health behavior and its outcomes are necessary in 
order to initiate behavior change (Jeste, Dunn, Folsom, & Zisook, 2008).  However, 
research has failed to demonstrate that solely providing information (e.g., pamphlet) will 
lead to a change in risk-reduction behavior (Shepherd et al., 2000; St. Lawrence & 
Fortenberry, 2007).   
As reported by previous researchers (Dworkin et al., 2006; Jemmott & Jemmott, 
2000), theory-based group interventions are the most effective interventions for HIV and 
STI risk reduction.  The Theory of Planned Behavior in particular (TPB; Ajzen, 1991) 
has been influential in providing a framework for designing effective interventions. A 
significant amount of research supporting this model has been conducted on a variety of 
health behaviors, including sexual risk behaviors (Armitage & Conner, 2001; Hardeman 
et al., 2002).  An extension of the Theory of Reasoned Action (TRA; Ajzen & Fishbein, 
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1980), TPB is a cognitive theory developed to assist in the explanation of behavioral 
action and behavior change.  TPB proposes that behavior is primarily influenced by 
behavioral intentions.  These intentions are influenced by an individual’s beliefs about a 
behavior, including the consequences (behavioral beliefs), which in turn foster attitudes 
towards the behavior.  Further, intentions are influenced by an individual’s perceptions of 
others’ beliefs (normative beliefs) (Ajzen, 2002) which shape their perception of social 
pressure to engage in the behavior (subjective norms).  Lastly, TPB proposes that an 
individual’s intentions are influenced by beliefs about barriers or aids that may encourage 
or impede performance of the behavior” (control beliefs) (Ajzen, 2002) which then lead 
to one’s perceived ability to engage in the target behavior (perceived behavioral control).  
It is the additive nature of the three behavioral influences mentioned (attitude toward the 
behavior, subjective norm, and perceived behavioral control) that forms the behavioral 
intention – “the central factor in the theory of planned behavior” (Ajzen, 1991, p. 181).   
In other words, in order for an individual to engage in a risk-reduction behavior such as 
condom use, she must have the knowledge and information necessary to develop beliefs 
that would support behavioral intentions about condom use.   
For example, she must have the belief that using condoms would be effective at 
reducing her risk of negative consequences, which would lead her to have a positive 
attitude towards condom use.  She must also have information supporting a social 
expectation for condom use or believe that the majority of her peers use condoms.  This 
would lead her to perceive a significant amount of social pressure to use condoms.  
Lastly, she must be knowledgeable about the possible impediments to condom use (e.g., 
partner cooperation; proper condom use) and how to address those problems, allowing 
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her to believe she possesses the skills necessary to negotiate condom use with a partner 
and properly use a condom.  If these factors are in place, the individual is more likely to 
be motivated to use a condom.   
It is this motivation (i.e., intention to behave), according to TPB that will lead to 
consistent condom use (Ajzen, 1991; Albarracin, Johnson, Fishbein, & Muellerleile, 
2001).  Therefore, interventions based on TPB must focus on changing the behavioral, 
normative, and control beliefs of participants by providing the information, skills, and 
problem-solving strategies (Hardeman et al., 2002).  By altering beliefs, changes in 
attitudes, in subjective norms, and in perceived behavioral control can then occur (Ajzen, 
1991; Fisher, 1997).  Research examining the impact of HIV behavioral interventions 
based on TPB has generally upheld its theoretical assumptions and demonstrated that 
these interventions are effective at increasing risk-reduction behaviors such as reducing 
the frequency of sex with multiple partners (Jemmott, Jemmott, & Fong, 1998) and 
unprotected sex (Albarracin, Durantini, & Earl, 2006; Jemmott et al., 1998; Jemmott, 
Jemmott, Fong, & Morales, 2010).        
Given the overlap between HIV and HPV sexual risk behaviors believed to 
contribute or lead to infection, HPV interventions could borrow components from HIV 
programs that are proven effective (McCree et al., 2007), such as encouraging regular 
STI/HIV testing and discussing STIs/HIV with new partners (Burk, et al., 1996; Dell et 
al., 2000; Gerend & Magliore, 2008).  In addition, programs incorporating a focus on 
abstinence or reduction in new sexual partners are more effective in preventing HIV than 
those that do not promote this strategy (DiClemente et al., 2007).  Condom use is a 
known risk-reduction strategy against HIV infection (CDC, 2010a).  Although condoms 
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do not completely protect against HPV infection (CDC, 2010a; Winer et al., 2006), 
studies have shown that condom use can significantly reduce risk of infection (CDC, 
2010a).  Additionally, consistent condom use has been correlated with faster recovery 
from infection and a sireduced likelihood of re-infection (Bleeker, et al., 2003; 
Hogewoning et al., 2003; Holmes, Levine, & Weaver, 2004).  Similar to HIV 
intervention programs, HPV intervention programs should emphasize the importance of 
frequent STI testing and Pap smears, discussing STIs with new partners, abstinence or a 
reduction in the number of sexual partners (Baer, Allen, & Braun, 2000; Yacobi et al., 
1999), and proper barrier contraceptive use (Hogewoning et al., 2003; Holmes et al., 
2004).  Additionally, the consequences of the infection such as cervical and other cancers 
(e.g., vulva, vagina, anus, and neck), and the necessary medical treatments, should be 
addressed (Baer et al., 2000; Yacobi et al., 1999). 
In conclusion, although many components of traditional HIV interventions appear 
very applicable to HPV risk reduction, there are some differences that may require 
special adaptations for HPV risk-reduction interventions (Baer et al., 2000).  For 
example, although condoms are less effective in reducing HPV infection than with other 
STIs, they do significantly reduce infection risks (McCaffery et al., 2003; Winer et al., 
2006). Likewise, interventions must emphasize the prevalence and ease of transmission 
of HPV.  HPV educational campaigns and interventions should target women (Baer et al., 
2000) given the higher rate of serious health consequences and fatality attributed to HPV 
among women (Ferris et al., 2008; Lopez, Tanjasiri, & McMahan, 2008; Parkin & Bray, 
2006).  Lastly, it is important to note the effectiveness of the vaccine in prevention of the 
four types of HPV associated with cervical cancer and genital warts (Zimet et. al, 2010) 
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while addressing the barriers, including (but not limited to) beliefs and lack of access, 
that often prevent women from receiving this vaccination (Gerend & Magloire, 2008; 
Liddon et al., 2007; Zimet et al., 2010). 
With these additions, current HIV group interventions might easily be translated into 
effective HPV group interventions.  
Present Study 
Given the high rate of infection among college women and associated 
consequences of HPV, it is necessary to gain a more thorough understanding of the most 
effective ways to reduce the risk of HPV infection.  Currently, there is little information 
regarding the effectiveness of HPV risk-reduction interventions.  By developing an 
effective, theory-based intervention, health care providers and educators should be more 
successful in their efforts to intercede and prevent infection with HPV or, if already 
infected, prevent more negative consequences (e.g., infecting others) from occurring.   
Using a randomized design, the current study examined the effectiveness of an 
HPV educational group intervention developed for this study that was based on previous 
HIV and HPV risk-reduction research and guided by the principles of TPB (Ajzen, 1991) 
compared to a control condition.  The intervention was provided in a standard, in-person 
group format (see Chapter 2 for more information about the intervention).  The control 
condition consisted of participants viewing an academic skills building video.  As 
suggested, the intervention targeted women given the high rate of infection, ease of 
transmission, and impact of cervical cancer among women (Baer et al., 2000; Ferris et al., 
2008; Lopez et al., 2008).  Additionally, only sexually active (e.g., anal, oral, and/or 
vaginal sex within the past month) women were included in the study to ensure that the 
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effects of the intervention on risk reduction could be exemplified by demonstrating a 
change in sexual risk-reduction behavior in addition to knowledge.  Lastly, the study only 
included women who had not begun or completed the HPV-vaccine series to determine 
the impact of the intervention on this outcome.   
 Measures were completed prior to the intervention, immediately after the 
intervention, and one month post-intervention (Fisher, 1997).  All participants completed 
all pre-test and post-test measures in the lab.  Follow-up measures were completed 
outside of the lab, on participants’ personal computers or any computer of their choice.  
Attrition rates were expected to be consistent with previous comparable interventions 
using a 1-6 month follow-up (Kamb et al., 1998; Petersen, Albright, Garrett, & Curtis, 
2007; Robin et al., 2004) in the range of 15% to 35%. 
Study Outcomes 
 The evaluation of the program effectiveness was informed by TPB (Ajzen, 2002).  
As stated in TPB (Ajzen, 1991), behaviors are directly influenced by an individual’s 
intention to engage in that behavior (behavioral intentions).  Behavioral intentions are 
influenced by the individual’s beliefs about a behavior which are developed through 
information and knowledge, attitudes towards the behavior, her level of perceived social 
pressure for engaging in the behavior (subjective norms), and her perception of control 
for the behavior (perceived behavioral control).  Therefore, the anticipated outcomes of 
the study included changes in the following: 1) HPV knowledge, 2) attitudes towards 
sexual risk-reduction behaviors (e.g., reducing new sexual partners, using barrier 
contraceptives, discussing STIs with partners, receiving HPV vaccine, seeking 
information on HPV, receiving a Pap smear, getting tested for HIV and other STIs), 3) 
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subjective norms in association with the risk-reduction behaviors, 4) perceived behavioral 
control of the risk-reduction behaviors, 5) intention to perform the risk-reduction 
behaviors, and 6) the actual risk-reduction behaviors.   
Specific Aim and Hypotheses  
The study was an exploratory study developed in order to advance the field of 
sexual risk reduction with regards to HPV.  The goal of the study was to examine the 
effectiveness of a group intervention in sexual risk-reduction behaviors specific to human 
papillomavirus (HPV) among college-aged women.  The intervention was a single-
session group intervention based on previous HIV and HPV risk-reduction research and 
guided by the principles of TPB (Ajzen, 1991).  The measured outcomes corresponded to 
the factors associated with behavior change according to TPB (Ajzen, 1991; Francis et 
al., 2004).  Participants completed outcome measures pre-intervention, immediately post-
intervention, and at a one-month follow-up.  The multiple time points, along with a 
control group, were designed to allow the impact of the intervention to be assessed both 
between and within groups. The specific aims of the study were as follows: 
 Aim.  To determine the effectiveness of the intervention on HPV risk reduction 
consistent with TPB (Ajzen, 1991) by:  
a) Examining changes in participants’ scores on non-behavioral indicators (e.g., 
knowledge, intentions, attitudes, social norms, and perceived control) from pre-
test (T1) to immediate post-test (T2).  
a. Hypothesis 1:  From T1 to T2, it was expected that scores on knowledge, 
intentions, attitudes, social norms, and perceived control for participants in 
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the intervention condition would show a significant increase over baseline 
levels compared to the control group. 
b) Examining changes in participants’ scores on non-behavioral indicators from T2 
to one-month post-intervention (T3). 
a. Hypothesis 2:  Participants’ scores on knowledge, intentions, attitudes, 
social norms, and perceived control were expected to remain consistent 
from T2 to T3. 
c) Examining changes in participants’ scores on non-behavioral indicators from T1 
to T3. 
a. Hypothesis 3:  It was expected that scores on measures of knowledge, 
intentions, attitudes, social norms and perceived control would increase 
significantly from T1 to T3 for participants in the intervention condition 
whereas those in the control condition will not. 
d) Examining changes in participants’ sexual risk-reduction behaviors from T1 to 
T3. 
a. Hypothesis 4:  From T1 to T3, it was predicted that risk-reduction 
behaviors (e.g., reducing new sexual partners, using barrier contraceptives, 
discussing STIs with partners, receiving HPV vaccine, seeking 
information on HPV, receiving a Pap smear, getting tested for HIV and 
other STIs, abstaining from cigarette use) would increase for participants 
in the intervention condition.   
 
 
 
CHAPTER 2:  MATERIALS AND METHOD 
 
 
Participants 
Participants were undergraduate students enrolled in undergraduate psychology 
courses at a state-supported university in the southeastern U.S.  Eligibility criteria for the 
study required that participants were English-proficient females aged 18-24.  
Additionally, only participants who had engaged in oral, anal, and/or vaginal sex in the 
previous month were recruited.  Participants who had begun or completed the HPV-
vaccine series were ineligible.   
Participants were recruited through the university’s online recruiting website that 
was developed by SonaSystems®, a site monitored and maintained by a university 
psychology faculty member.  A brief description of the study, emphasizing the necessary 
one-month follow-up, was placed on the site (see Appendix B).  Pre-screen questions (see 
Appendix C) prevented ineligible participants from being able to view the study 
description and sign up for participation.  To maximize recruitment and retention, 
participants received two credits towards their course requirements for completion of the 
first phase of the study.  Upon completion of the follow-up, participants received an 
additional course credit and entry into a drawing to win one of ten $50 Target gift 
certificates, resulting in a one in twelve chance of winning a gift certificate.   
Based on power analysis using GPower (Faul, Erdfelder, Lang, & Buchner, 2007) 
calculations to detect a medium effect (f 2=.15), the inclusion of n = 43 per condition, and 
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N = 86 would allow sufficient power (.80; alpha = .05) to detect the effect of the 
intervention.  To accommodate for an estimated 15% to 35% attrition rate (Kamb et al., 
1998; Petersen et al., 2007; Robin et al., 2004), the targeted sample size was N = 116 (n 
= 58 per condition).   To maximize retention, participants were contacted 21 days 
following their participation in part one of the study by e-mail.  Participants were 
contacted once again 28 days after completing part 1 of the study and instructed to sign-
up on UNCC SonaSystems® and complete part 2 of the study.  Participants who failed to 
complete follow-up measures within 31 days following participation in part 1 of the study 
were dropped from the study. 
Sample 
The original sample consisted of 105 female undergraduate students, primarily 
Caucasian, ranging from age 18 to 29.  Prior to participating in the study, participants 
were randomly assigned to the intervention group (n=58) or the control group (n=47).  A 
total of 14 participants failed to complete the follow-up (T3) portion of the study, 
resulting in an attrition rate of 13.33% (18.9% from the control group, 6.4% from the 
intervention group).  Based on exclusion criteria, 9 participants (4 from the intervention 
condition; 5 from the control condition) were removed due to their sexual history (e.g., 
not sexually active in the past month), age (e.g., over 24 years old), relationship status 
(e.g., married), or failure to report their sexual orientation.  
The final sample included 82 female undergraduates with 42 participants in the 
control group and 40 participants in the intervention group.  Mean age of participants was 
20.00 years (SD = 1.57) with a range of 18 to 23.  The sample consisted of 21 (25.6%) 
freshman, 23 (28%) sophomores, 20 (24.4%) juniors, 16 (19.5%) seniors, and 2 (2.4%) 
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post-baccalaureate students.  Participants primarily identified as Caucasian (56.1%) or 
African-American (28%).  The remaining participants identified as bi-racial (9.8%), 
Asian-American (3.7%), or Latina (2.4%).  With regards to relationship status, 22% of 
participants were unmarried and not dating and 19.5% were dating one or more people, 
47.6% were in a relationship but not cohabitating, 11% were living with a partner but not 
married.  Among the 48 participants reportedly in a relationship, 56.3% had been in that 
relationship for over a year.  The majority (91.5%) of participants identified as 
heterosexual, while the remaining participants identified as either bisexual (7.3%) or 
other (1.2%).  Forty-three percent of participants reported hormonal contraceptive use.  
There were no significant differences across groups in terms of age, race, education level, 
relationship status, relationship length, and sexual orientation based on analysis of the 82 
valid cases.   
Measures  
Participants completed measures at three time points: pre-test (T1), post-test (T2), 
and follow-up (T3).  Measures at T1 and T3 took approximately 15-30 minutes to 
complete while measures at T2 took approximately 5-10 minutes to complete.  Pre-test 
measures (T1; Appendix D) were given immediately prior to the initiation of the 
condition in order to assess baseline levels of targeted outcomes: 1) HPV knowledge, 2) 
attitudes towards risk-reduction behaviors, 3) subjective norms in association with the 
risk-reduction behaviors, 4) perceived behavioral control of the risk-reduction behaviors, 
5) intention to perform the risk-reduction behaviors, and 6) the actual risk-reduction 
behaviors.  Post-test measures (T2; Appendix E) were given immediately following the 
completion of the intervention condition in order to determine the immediate impact of 
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the intervention on the targeted outcomes.  Lastly, follow-up measures (T3; Appendix D) 
were administered one-month after completion of Part 1 to determine the long-term 
impact of the intervention on the targeted outcomes. 
Identifier.  All participants were asked to provide an identifier at each assessment 
point in order to link all three time points for analysis.  Participant identifiers consisted of 
the first three letters of their middle name, the first three letters of their birth city, and the 
first three letters of their mother's maiden name, resulting in a 9-letter code.   
Demographics.  Participants were asked to report their age, ethnicity/race, sexual 
orientation, education level, and relationship status (Herbenick et al., 2010; Lambert, 
2001).  This measure was collected at T1 and T3 (see Appendix D).     
HPV Knowledge Scale (HKS).  Participants were instructed to complete Daley 
and colleagues’ (2008) 20-item HPV Knowledge Scale assessing their knowledge of 
HPV with regard to the consequences (e.g., “HPV causes herpes”), causes (e.g., “HPV is 
spread on toilet seats”), identification (e.g., “You can have HPV without knowing it”), 
and control (e.g., “Using a condom will decrease the chance of transmitting warts”) of 
HPV.  Participants responded to the scale by choosing “True,” “False,” or “Not Sure (1).”  
Certain items were reverse scored such that “2” indicated correct, “1” indicated not sure, 
and “0” indicated incorrect.  Item scores were averaged to determine knowledge of HPV 
as indicated by this measure.  Higher scores indicate higher levels of knowledge with the 
highest possible score of 2.  Daley and colleagues (2008) reported a split-half reliability 
coefficient of .806.  Using the Spearman-Brown correction, the split-half reliability was 
assessed for each time point in this study:  T1 (.716), T2 (.804) and T3 (.637).   
24 
 
Future Intentions Survey (FIS).  Participants completed a 10-item survey 
developed from previous research (Bryan et al., 1996; Burak & Meyer, 1997; Farrell et 
al., 2008; Fisher, Fisher, Misovich, Kimble, & Malloy, 1996; Francis et al., 2004; Lopez 
& McMahan, 2007; McPartland, Weaver, Lee, & Koutsky, 2005) to examine the 
likelihood of engaging in specific risk-reduction behaviors (e.g., reducing new sexual 
partners, using barrier contraceptives, discussing STIs with partners, receiving HPV 
vaccine, seeking information on HPV, receiving a Pap smear, getting tested for HIV and 
other STIs).  Responses were provided using a 3-point Likert scale (e.g., “To what degree 
do you in intend to use condoms with a new sexual partner in the next month?”:  I do not 
intend to [0], undecided [1], and I intend to [2]).  Item scores were averaged to determine 
intentions to engage in sexual risk-reduction behaviors.  The highest possible score was 
2, with higher scores indicating greater intentions to perform the risk-reduction 
behaviors.  Cronbach’s alphas for the time points of T1, T2, and T3 were .645, .749, and 
.752, respectively.   
Attitudes Toward Intentions (ATI). Participants completed a 20-item survey 
designed to assess participants’ attitudes towards the behavioral intentions assessed in the 
FIS (Francis et al., 2004) (e.g., “Reducing the number of sexual partners I have is”; 
“Engaging in unprotected vaginal intercourse is”).  Responses were provided using a 3-
point Likert scale (e.g., “good,”  “neither good nor bad,” “bad”; “harmful,” “neither 
harmful nor beneficial,” “beneficial”).  Certain items were reverse scored.  Item scores 
were averaged, with higher scores (highest possible score of 2) indicating more positive 
attitudes towards risk-reduction behaviors (e.g., reducing new sexual partners, using 
barrier contraceptives, discussing STIs with partners, receiving HPV vaccine, seeking 
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information on HPV, receiving a Pap smear, getting tested for HIV and other STIs).  This 
assessment was used at all time points (i.e., T1, T2, and T3) and Cronbach’s alphas for 
each of the time points were .775, .678, and .797, respectively. 
Subjective Norms (SN).  Participants completed a 10-item survey designed to 
assess the level of social pressure they experience in relation to performing the risk-
reduction behaviors assessed in the FIS (Francis et al., 2004) (e.g., “I feel under social 
pressure to use a condom with a partner”; “I feel under social pressure to reduce the 
number of new sexual partners I have”).  Responses were provided using a 5-point Likert 
scale (e.g., 0-4; “Strongly disagree” to “Strongly agree”) with higher scores indicating 
greater perceived social pressure to engage in the behaviors assessed (e.g., reducing new 
sexual partners, using barrier contraceptives, discussing STIs with partners, receiving 
HPV vaccine, seeking information on HPV, receiving a Pap smear, getting tested for HIV 
and other STIs).  Certain items were reverse scored.  Item scores were averaged to create 
the scale sore (0-4).  Cronbach’s alphas for each of the three time points (i.e., T1, T2, and 
T3) were .754, .832, and .816, respectively.   
Perceived Behavioral Control (PBC).  Participants completed a 20-item survey 
designed to assess participants’ perceived behavioral control for performing the risk-
reduction behaviors assessed in the FIS (Francis et al., 2004).  There are two scales 
comprising the measure with each scale consisting of 10 items.  The first scale assessed 
participants’ level of self-efficacy for performing the risk-reduction behavior (e.g., “I am 
confident that I can reduce the number of new sexual partners I have if I wanted to”).  
The second scale assessed participants’ level of perceived controllability of the risk-
reduction behavior (e.g., “Whether or not I reduce the number of new sexual partners I 
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have is entirely up to me”).  Items were scored on a 5-point Likert scale (e.g., 0-4; 
“Strongly disagree” to “Strongly agree”).  Certain items were reverse scored.  Item scores 
were averaged with higher scores (highest possible score of 4) indicating greater 
perceived behavioral control for the risk-reduction behaviors (e.g., reducing new sexual 
partners, using barrier contraceptives, discussing STIs with partners, receiving HPV 
vaccine, seeking information on HPV, receiving a Pap smear, getting tested for HIV and 
other STIs).  This assessment was used at all time points (i.e., T1, T2, and T3) and 
Cronbach’s alphas for each of the time points were .894, .917, and .919, respectively.  
Sexual Health and History Survey (SHHS).  Participants were asked to answer 
seventeen questions about their sexual history (e.g., “How many opposite-sex vaginal 
intercourse partners have you had in your lifetime?”; “Approximately how many times 
have you received a Pap smear in your lifetime?”).  Skip patterns were built into the 
measure such that depending on the participants’ response, they were prompted to answer 
another series of questions.  The total number of possible questions was sixty six, 
including both close-ended (e.g., “yes” or “no,” “never” to “rarely”) or open-ended (e.g., 
“How many times have you had oral sex with opposite-sex partners in the past 1 
month?”) with a minimum of 13 total responses.  The questions were developed for this 
study and based on previous research assessments of sexual risk behavior associated with 
HPV (Burak & Meyer, 1997; Burk et al., 2006; Conroy et al., 2009; Dell et al., 2000; 
Gerend & Magliore, 2008; Ingledue et al., 2004; Sikstrőm, Hellberg, Nilsson, Brihmer, & 
Mardh, 1996; Vail-Smith & White, 1992; Winer et al., 2003) and other STIs/HIV 
(DiClemente et al., 2007; Gavin et al., 2009; McFarlane, Bull, & Reitmeijer, 2002; 
Peterson et al., 2007; Roberto et al., 2007).   Given the wide range of responses due to the 
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built-in skip patterns, the items were assessed individually (Neumann et al., 2002) and no 
composite score was developed.  The items of interest included the number of new sexual 
partners, the use of barrier contraceptives, discussion of STIs with sexual partners, receipt 
of the HPV vaccine, HPV-information seeking, receipt of a Pap smear, HIV testing, STI 
testing, and cigarette use.   This assessment was used at both T1 and T3.   
Intervention Design  
Similar to Lambert (2001), the intervention condition consisted of a single session 
lasting approximately one hour.  Guided by TPB (Ajzen, 2002), the aim of the 
intervention was to improve participants’ knowledge, attitudes, subjective norms, and 
perceived behavioral control towards engaging in HPV risk-reduction behaviors (Fisher, 
1997).  According to TPB (Ajzen, 1991) creating positive change in those areas leads to 
an increase in participants’ intention to engage in the HPV risk-reduction behaviors, 
thereby increasing the likelihood that the participants engage in the targeted HPV risk-
reduction behaviors discussed in the intervention.    
The intervention was facilitated by the principal investigator to the participants in 
a group session ranging from 2-7 group members per session.  Power point slides along 
with facilitator led discussion provided a significant amount of basic, factual information 
about HPV (Jemmott et al., 2010).  By providing such information, participants should be 
able to develop more accurate beliefs regarding HPV and HPV risk-reduction methods 
(Fishbein & Ajzen, 1975; Fisher, 1997; Hardeman et al., 2002).  The methods of risk 
reduction included strategies such as limiting the number of sexual partners (DiClemente 
et al., 2007), alternative sexual activities (e.g., non-penetrative sexual acts), discussion of 
sexual history and testing with potential sexual partners (Baer et al., 2000), and 
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knowledge regarding HPV (Burchell, Winer, de Sanjosé, & Franco, 2006).  Further, the 
use and limitations of condoms and alternative barrier contraceptives (e.g., female 
condoms) (Burchell et al., 2006; Dworkin et al., 2006; Neumann et al., 2002; Winer et 
al., 2006) along with the importance of discussing protective methods with potential 
partners was discussed during this segment (Hiltabiddle, 1996).  Recommendations 
included annual Pap smears to detect abnormalities along with regular STI testing 
(Juszczyk, 2009) and the HPV-vaccine (CDC, 2009a).  Lastly, a discussion of how these 
interventions apply to individuals who may already be infected with HPV was included.  
For example, while a participant may already be infected with one of the 4 types of HPV 
that the vaccine was designed to prevent, it is highly unlikely she was infected with all 
four (Garland et al., 2007).  As a result, she would still benefit from the vaccine.  It was 
also noted that the use of condoms while infected with HPV can reduce the likelihood of 
re-infection and is associated with a faster recovery from infection (Bleeker, et al., 2003; 
Hogewoning et al., 2003; Holmes et al., 2004).   
For each of the risk-reduction behaviors, information aimed at increasing positive 
attitudes towards engaging in the risk-reduction behavior (e.g., reducing new sexual 
partners, using barrier contraceptives, discussing STIs with partners, receiving HPV 
vaccine, seeking information on HPV, receiving a Pap smear, getting tested for HIV and 
other STIs) was provided (Albarracin et al., 2001; Fisher, 1997; Hardeman et al., 2002; 
Jemmott et al., 2010) by providing more accurate information regarding the efficacy of 
risk-reduction methods and improve judgments towards the behaviors.  Consistent with 
previous research recommendations (Jeste et al., 2008; Ingledue et al., 2004), information 
such as the definition and description of the disease along with prevalence and incidence 
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rates (Burchell et al., 1996) and methods of transmission (Burchell et al., 2006; CDC, 
2007) was presented.  The disease course including the asymptomatic nature of HPV, the 
use of Pap smears to detect HPV, the lack of treatment for HPV, and the tendency for 
HPV to regress naturally was discussed (CDC, 2007; Vega & Ghanem, 2007).  Health 
conditions or consequences related to HPV were presented.  For example, HPV types 6 
and 11 cause the majority of genital warts cases (National Cancer Institute [NCI], 2008), 
while HPV types 16 and 18 are responsible for at least 70% of cervical cancer diagnoses, 
and approximately 30% of vaginal, anal, and neck cancers (Muñoz, Castellsagué, de 
González, & Gissman, 2006).  Additionally, known infection risk factors such as multiple 
sexual partners (Burchell et al., 2006), sex (e.g., anal, oral, and vaginal) without 
protective barriers (e.g., condoms or other barrier contraceptives), and intercourse with 
partners who engage in sexual risk behaviors was discussed (Burchell et al., 2006).  
Participants were informed of the specific factors associated with the college 
environment that increase their risk such as the availability of multiple sex partners.  
Additionally, the incidence of HPV-related cancers (Parkin & Bray, 2006) and genital 
warts (NCI, 2008) was summarized.  Also included were health risk factors associated 
with the development of HPV-related cancers, such as cigarette use (Burchell et al., 2006; 
Muñoz et al., 2006), a history of STIs, as well as a lack of Pap smears and STI testing 
(Burak & Meyer, 1997). 
General information regarding current rates of condom use and other risk-
reduction behaviors and expectations of behaviors, such as receiving a Pap smear, 
assisted in building beliefs regarding the social pressure to engage in the risk-reduction 
behaviors (Albarracin et al., 2001; Elder, Ayala, & Harris, 1999).  Additionally, group 
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discussion and participants’ self-report of the risk-reduction behaviors such as frequency 
of STI testing behaviors and expectations for condom use and provision were 
encouraged.   
To increase participants’ perceived behavioral control for engaging in the risk-
reduction behaviors, the potential difficulties associated with completing the risk-
reduction behaviors were noted (Albarracin et al., 2001), such as the cost of the HPV-
vaccine (Conroy et al., 2009; Gerend & Magliore, 2008; Liddon et al., 2007; Zimet et al., 
2010), or the discomfort associated with buying condoms or discussing use with a partner 
(Hiltabiddle, 1996; Jemmott et al., 2010).  Additionally, barriers to the use of condoms 
and other barrier contraceptives were addressed (Hiltabiddle, 1996).  These include 
beliefs regarding condoms as inconvenient, uncomfortable, difficult to use, and 
embarrassing to purchase or acquire (Bryan et al., 1996).  Barriers to Pap smears, such as 
discomfort and cost were addressed (Burak & Meyer, 1997).  Lastly, a discussion about 
barriers to STI testing was noted, including the psychological impact of an STI diagnosis 
(Juszczyk, 2009; McCaffery et al., 2003; Vega & Ghanem, 2007).   
With each obstacle, ways of overcoming the challenge and successfully engaging 
in the risk-reduction behavior were discussed.  Participants were encouraged to problem 
solve methods for overcoming the barriers to executing the risk-reduction behavior 
(Albarracin et al., 2001; Neumann et al., 2002).  For example, a discussion about the 
specific medical procedures such as the vaccine, Pap smears and STI testing was covered 
(Burak & Meyer, 1997; Chapman et al., 2010) including locations to receive these 
procedures, anticipated cost, and methods for handling insurance.  A discussion of ways 
to address the barriers to condom use and other barrier contraceptives occurred during 
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this segment (Lopez & McMahan, 2007), including locations to acquire and purchase 
condoms and other barrier devices (Bryan et al., 1996), videos demonstrating proper use 
of condoms (Hogewoning et al., 2003; Holmes et al., 2004) and other barrier 
contraceptives (Dworkin et al., 2006; Van Devanter et al., 2002).  Further, methods of 
discussing condom use, sexual history, and STI testing with potential partners were 
reviewed (Burk et al., 1996; Dell et al., 2000; Gerend & Magliore, 2008; Hiltabiddle, 
1996; Jemmott et al., 2010).  For example, participants were encouraged to have these 
discussions in a ‘safe’ location (e.g., not alone with the potential partner in a dorm room) 
prior to being intimate instead of waiting for the ‘heat of the moment’ to have the 
discussions.  For a general outline of the intervention see Appendix A and for a copy of 
the intervention slides see Appendix G.   
Procedures 
After reading a description of the study listed on the UNCC psychology 
recruitment site, eligible participants signed up for Part 1 of the study (time, date, 
location).   Each intervention group was limited to a maximum of 8 participants (Rew et 
al., 2007).  Participants were reminded that signing up for Part 1 required they also 
complete Part 2, a brief online survey.   
Part 1.   
 Intervention.  When the participants presented for their assigned time for Part 1, 
they were instructed to sit at a computer with a chair (the chair from every other 
computer was removed in order to provide more privacy).  Prior to beginning, the 
facilitator ensured that participants were sitting at least one computer apart 
(approximately 4 feet apart).  Once this had been confirmed, participants were provided 
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with the Informed Consent form (Appendix F).  They were instructed to read the form 
carefully prior to signing.  Additionally, the facilitator discussed key points of the form 
(e.g., voluntary participation, one-month follow-up required, contact information for the 
UNCC Counseling Center and IRB office).   
 Pre-test (T1).  Once the informed consent forms were complete, the participants 
were given a card listing instructions for completion of the surveys.  The card also 
reminded participants to remain seated after completing the surveys.  Participants were 
then instructed to begin answering the computer-based surveys, using SurveyShare®.  At 
that time (T1), participants completed the Demographics, HPV Knowledge Scale (HKS), 
Future Intentions Survey (FIS), Attitudes Toward Intentions (ATI), Subjective Norms 
(SN), Perceived Behavioral Control (PBC), and Sexual Health and History Survey 
(SHHS) measures (Appendix D).   
 Upon completion of the measures, participants received the intervention.   In the 
intervention condition, participants were instructed to remain present for a brief, 
approximately 60-minute lecture and discussion (range = 55 minutes to 65 minutes).  At 
that time, they were directed to a designated section of the room and asked to sit in one of 
the chairs provided.  The facilitator began by reintroducing herself and reminding 
participants that participant information discussed in the group setting was confidential 
and not to be discussed elsewhere.  Upon that time, the facilitator invited the participants 
to ask any questions they may have.  After addressing the questions, Microsoft Power 
Point slides (see Appendix G) were projected onto a large screen so that all participants 
could see the information.  The facilitator began by presenting slides that addressed the 
questions on the HKS. Participants were encouraged to discuss their knowledge of HPV 
33 
 
at that time and any concerns they had.  The facilitator also presented slides providing the 
known risk factors of HPV.  In addition, slides with information regarding methods of 
risk reduction along with barriers to utilizing those methods and societal expectations 
regarding use were presented and discussed while any questions or comments from 
participants were addressed.  Lastly, slides and a discussion describing various ways to 
discuss STIs/HIV and initiate condom use with sexual partners ensued.   
 Post-test (T2).  Once the intervention was complete, participants were instructed 
to complete the post-test measures (T2) which consisted of the HKS, FIS, ATI, SN, and 
PBC measures (Appendix E).  These measures were completed through SurveyShare®. 
Following completion of the post-test measures, the participants were informed that the 
facilitator had collected their email addresses through SonaSystems® and would email 
them one week prior to follow-up as a reminder that they are to complete Part 2.  
Additionally, they were informed that on the day the participants were to complete the 
online survey, the facilitator would email an invitation code for participants to sign-up 
and complete part 2 of the study through SonaSystems®.   
 Participants were given a card thanking them for their participation, reminding 
them of the importance of completing the follow-up measures in 28 days, and included 
the principal investigator’s email and the faculty supervisor’s contact information (e-mail 
and office phone).   
 Control.  When the participants presented for their assigned time for Part 1, they 
were instructed to sit at a computer with a chair (the chair from every other computer was 
removed in order to provide more privacy).  Prior to beginning, the facilitator ensured 
that participants were sitting at least one computer apart (approximately 4 feet apart).  
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Once that had been confirmed, participants were provided with the Informed Consent 
form (Appendix F).  They were instructed to read the form carefully prior to signing.  
Additionally, the facilitator discussed key points of the form (e.g., voluntary 
participation, one-month follow-up required, contact information for the UNCC 
Counseling Center and IRB office).   
 Pre-test (T1).  Once the informed consent forms were complete, the participants 
were given a card listing instructions for completion of the surveys.  The card also 
reminded participants to remain seated after completing the surveys.  Participants were 
then instructed to begin answering the computer-based surveys, using SurveyShare®.  At 
that time (T1), participants completed the Demographics, HKS, FIS, ATI, SN, PBC, and 
SHHS measures (Appendix D).   
 Upon completion of the measures, participants began the control intervention.  In 
the control condition, participants were instructed to remain at their computer.  
Participants were then instructed to type in the web address 
(http://www.youtube.com/watch?v=9oWgHj7QPHw) that directly linked them to the 45-
minute online video detailing study skills.  The participants were instructed to watch the 
entire video.   
 Post-test (T2).  Once the intervention was complete, participants were instructed 
to complete the post-test measures (T2) which consisted of the HKS, FIS, ATI, SN, and 
PBC measures (Appendix E).  These measures were completed through SurveyShare®. 
Following completion of the post-test measures, the participants were informed that the 
facilitator had collected their email addresses through SonaSystems® and would email 
them one week prior to follow-up as a reminder that they are to complete Part 2.  
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Additionally, they were informed that on the day the participants were to complete the 
online survey, the facilitator would email an invitation code for participants to sign-up 
and complete part 2 of the study through SonaSystems®.   
 Participants were given a card thanking them for their participation, reminding 
them of the importance of completing the follow-up measures in 28 days, and included 
the principal investigator’s email and the faculty supervisor’s contact information (e-mail 
and office phone).   
 Follow-Up (T3).  Approximately three weeks after completion of the post-test, 
participants were contacted by email and reminded of the date of their follow-up 
(Appendix H).  Twenty-eight days after participating in Part 1, the principal investigator 
emailed the invitation code to participants in order for them to complete Part 2 of the 
study (Appendix I).  In the email, participants were instructed to log onto SonaSystems® 
and go to the study labeled "Behaviors - Part Two" where they entered the invitation code 
to complete the surveys.  At follow-up, all participants completed Demographics, HKS, 
FIS, ATI, SN, PBC, and SHHS measures through SurveyShare® (Appendix D).  Upon 
completion of the survey, the principal investigator emailed participants with the contact 
information for the UNCC Counseling Center, the UNCC Student Health Center, and the 
UNCC IRB office.  Additionally, the contact information for the principal investigator 
(email) and the faculty supervisor (office phone and email) was provided (Appendix J).  
Once 12 participants completed the follow-up measures, those 12 participants’ names 
were entered into a drawing to win a $50 gift card to Target.  The winner of the drawing 
was emailed and provided with instructions for how to receive the gift card.    
   
 
 
 
CHAPTER 3:  RESULTS 
 
 
Non-Behavioral Measure Analysis 
 Descriptive statistics for all scale score results (i.e., HKS, FIS, ATI, SN, and 
PBC) across conditions are presented in Table 1.  For each of the non-behavioral 
measures, participants scored in the moderate to high range at T1. Independent-samples t-
tests revealed no significant differences between conditions across T1 scores for all non-
behavioral measures.   
T1 to T2:  Hypothesis 1  
To test Hypothesis 1, a hierarchical regression analysis was used for measures 
with continuous response scales [e.g., knowledge (HKS), intentions (FIS), attitudes 
(ATI), social norms (SN), and perceived behavioral control (PBC)] with participants’ 
scores at T2 as the criterion variable.  Results are shown in Table 2. Baseline scores (i.e., 
scores at T1) were entered first, followed by the control variables of relationship status 
(0=single, 1=in a relationship) and sexual orientation (0=heterosexual, 1=other).  The 
predictor variable of group condition (0=control, 1=intervention) was added to create the 
third model to determine the effect of group condition after controlling for all other 
variables.  The group condition had a large effect (∆R2 = .44) on changes in HKS from 
T1 to T2.  After controlling for sexual orientation and relationship status, the intervention 
group’s average change in HKS scores from T1 to T2 was .32 points higher (on a scale of 
0 to 2) than the change demonstrated in the control group.  Similarly, group condition had
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 a large effect (∆R2 = .19) on changes in FIS from T1 to T2, such that the intervention 
group’s average change was .34 points higher (on a scale of 0-2) than the control group’s 
change from T1 to T2 after controlling for both sexual orientation and relationship status.  
In other words, participants in the intervention condition demonstrated a significantly 
higher increase in HKS and FIS scores immediately after the intervention as compared to 
the control condition.  The intervention had statistically significant but small effects on 
the changes in participants’ attitudes towards risk-reduction behaviors (∆R2 = .05) and 
perceived social norms (∆R2 = .03), such that participant in the intervention condition had 
more positive attitudes towards risk-reduction behaviors and a greater perceived social 
pressure to engage in risk-reduction behaviors. With respect to perceived behavioral 
control, the intervention showed a small effect (∆R2 = .02) though it was not statistically 
significant. These findings suggest that the intervention effectively increased knowledge 
and behavioral intentions, but had less agency when it came to addressing risk-reduction 
attitudes, social norms, and behavioral control.  However, it should be noted that the 
smaller effect sizes may be due to restricted range; participants’ pre-existing attitudes and 
perceptions of behavioral control at T1 were high, creating a ceiling effect.   
T2 to T3:  Hypothesis 2 
To test Hypothesis 2, a hierarchical regression analysis was used for measures 
with continuous response scales (e.g., HKS, FIS, ATI, SN, and PBC) with participants’ 
scores at T3 as the criterion variable.  Results are shown in Table 3.  Post-test (i.e., scores 
at T2) were entered first, followed by the control variables of relationship status 
(0=single, 1=in a relationship) and sexual orientation (0=heterosexual, 1=other).  The 
predictor variable of group condition (0=control, 1=intervention) was added to create the 
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third model to determine the effect of group condition after controlling for all other 
variables.  As anticipated, the effect of group condition on participants’ scores from T2 to 
T3 was minimal and not statistically significant; suggesting that maintenance of scores 
was not associated with group condition.   
T1 to T3:  Hypothesis 3 
To test Hypothesis 3, a hierarchical regression analysis was used for items with 
continuous response scales (e.g., HKS, FIS, ATI, SN, and PBC) with participants’ scores 
at T3 as the criterion variable.  Results are shown in Table 4.  Baseline scores (i.e., scores 
at T1) were entered first, followed by the control variables of relationship status 
(0=single, 1=in a relationship) and sexual orientation (0=heterosexual, 1=other).  The 
predictor variable of group condition (0=control, 1=intervention) was added to create the 
third model to determine the effect of group condition after controlling for all other 
variables.  The group condition had a large effect on changes in HKS from T1 to T3 (∆R2 
= .18).  After controlling for sexual orientation and relationship status, the intervention 
group’s change in HKS scores from T1 to T3 was .17 points higher than the change 
demonstrated in the control group.  Similarly, group condition had a medium effect on 
changes in FIS from T1 to T3 (∆R2 = .06), such that the intervention group’s change was 
.20 points higher than the control group’s change from T1 to T3 after controlling for both 
sexual orientation and relationship status.  In other words, participants in the intervention 
condition demonstrated a higher increase in HKS and FIS scores after the intervention 
and this increase was maintained one-month post-intervention as compared to the control 
condition, though the size of the effect at T3 is smaller than the initial change observed at 
T2 (see above).  The intervention had a small effect on the changes in participants’ 
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perceived social norms (∆R2 = .02) though it was not statistically significant.  Contrary to 
the hypothesized outcome, the effect of the intervention on the changes in participants’ 
attitudes towards risk-reduction behaviors and perceived behavioral control of the risk-
reduction behaviors was not statistically significant. Similar to the findings from T1 to 
T2, the intervention was not sufficient in initiating long-term changes in risk-reduction 
attitudes, social norms, and behavioral control.    
SHHS Behavior Analysis  
Descriptive statistics for the SHHS items are shown in Table 5. At T1, 
participants reported an average of 9.8 lifetime sexual partners with an obtained range 
from 1-41 and 2.01 (ranging from 1-4) sexual partners in the past month, with most of 
them being partners of the opposite-sex.  Very few participants had engaged in same-sex 
relationships (n=14).  The majority of sexual partners reported were vaginal sex partners 
and oral sex partners.  Very few participants reported anal sex partners (n=22).  As a 
result of the low levels of engagement, participants’ same-sex and anal sex behaviors 
were not assessed further.  At T1, participants reported rarely talking with partners about 
STIs or using barrier contraceptives with sexual partners.  At T1, few participants had 
received the HPV vaccine (11%), had been tested for HIV (39.5%), and smoked 
cigarettes (17.1%).  A majority of the participants had sought information on HPV 
(57.3%), received a Pap smear (64.6%), and had been tested for STIs (57.3%).    An 
independent-samples t-test revealed no significant differences between conditions across 
T1 scores for SHHS items of interest.    
Continuous Outcomes:  Hypothesis 4 
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To test Hypothesis 4, a hierarchical regression analysis was used for items with 
continuous response scales (e.g., number of lifetime sexual partners; number of sexual 
partners in the previous month; frequency of STI discussions with partners; frequency of 
barrier contraceptive use with partners) consistent with the analyses reported above.  See 
Tables 6-9 for results.  The intervention had a small effect on the change in participants’ 
number of sexual partners in the previous month (∆R2 = .02) though it was not 
statistically significant.  Small but not significant effects were also noted on the changes 
in participants’ frequency of discussions about STIs with vaginal (∆R2= .03) and oral sex 
partners (∆R2= .02).  Similarly, although a small effect of the intervention was noted on 
changes in participants’ frequency of barrier contraceptive use with oral sex partners (∆R2 
= .02), the change was not statistically significant.  Overall, group condition did not 
significantly predict a change in risk-reduction behaviors from T1 to T3, suggesting that 
the intervention failed to have a significant effect on participants’ behaviors. 
Dichotomous Outcomes:  Hypothesis 4 
For SHHS items with dichotomous outcomes (e.g., “Have you received one or 
more HPV vaccines?,” “Have you sought out any information on HPV?,” “Have you ever 
had a Pap smear?,” “Have you ever been tested for HIV?,” “Have you ever been tested 
for an STI?,” “Do you currently smoke cigarettes?”), a Chi-square test was used to assess 
differences between conditions from Time 1 to Time 3.  See Table 10 for complete 
results. Results from the analysis revealed significant differences between the groups for 
HPV information seeking behavior (“Have you sought out any information on HPV?”) 
and HIV testing behavior (“Have you ever been tested for HIV?”).  The results indicate 
that participants who received the intervention were more likely to seek information 
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about HPV than those who did not.  Similarly, participants in the intervention condition 
were more likely to get tested for HIV following the intervention than the control group.  
The intervention was not related to change in other dichotomous HPV risk-reduction 
behavioral variables (e.g., HPV vaccine, Pap smear, STI testing, abstaining from cigarette 
use).  However, it should be noted that the findings may be due to a pre-existing high 
rate; at T1, many participants had previously received a Pap smear and STI testing.  
Similarly, very few participants smoked cigarettes.  As such, the lack of significance may 
be a byproduct of the ceiling effect.   
Overall, these findings do provide some empirical support for a brief one-time 
educational intervention in eliciting positive change in the factors associated with HPV 
risk reduction.  Consistent with the hypotheses, the intervention was successful at 
increasing knowledge, behavioral intentions, HPV information-seeking and HIV testing 
and these changes were maintained over a one-month interval.  Modest increases in 
attitudes toward risk-reduction behaviors and in related self-efficacy were obtained 
immediately after the intervention, but not at follow-up. Contrary to the hypothesized 
outcome, the intervention was also not successful at creating increases in social norms 
and many of the risk reduction behaviors (e.g., reducing new sexual partners, using 
barrier contraceptives, discussing STIs with partners, receiving HPV vaccine, receiving a 
Pap smear, getting tested for STIs).    
 
 
CHAPTER 4:  DISCUSSION  
 
 
The purpose of this study was to advance the field of sexual risk reduction with 
regards to HPV.  The study was an exploratory study developed to determine the 
effectiveness of a group intervention on increasing sexual risk-reduction behaviors 
specific to HPV among sexually active, college-aged women.   
Non-Behavioral Indicators 
 T1 to T2:  Hypothesis 1.  Scores across all non-behavioral measures were 
assessed from Time 1 to Time 2 to determine the immediate impact of the intervention.  
Consistent with Lambert’s (2001) findings, the intervention successfully increased 
participants’ HPV-related knowledge compared to those in the control group, indicating 
that the intervention material was effective in providing factual material regarding HPV.  
Similarly, participants in the intervention group had greater positive change in their 
intentions to engage in the targeted risk-reduction behaviors (e.g., intentions to use 
condoms, intentions to receive STI testing) compared to the control group.  The 
intervention increased participants’ intentions to engage in the targeted behaviors, such 
that participants were more likely to report that they intended to engage in the targeted 
behaviors after completing the intervention as compared to their responses prior to the 
intervention.  Further, these changes were higher in the intervention group, compared to 
the control group, suggesting that the results can be attributed to the intervention.  
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   Smaller changes were noted in attitudes towards engaging in the risk-reduction 
behaviors in the intervention group.  The change was minimal with respect to the 
intervention group’s perceived behavioral control for the risk-reduction behaviors (e.g., 
perceived control for reducing the number of sexual partners or using condoms).  Of note, 
in both groups, participants’ pre-existing attitudes towards the risk-reduction behaviors 
along with the perceived behavioral control were already quite high.  Although 
disappointing for this study because the ceiling effect limited the ability to draw 
conclusions regarding the efficacy in these two areas, these findings are positive.  Higher 
scores prior to engaging in the intervention suggest that attitudes and perceived control of 
the sample were in the desirable range.  Approximately half of the participants indicated 
that they had not received information about HPV prior to the study.  The other half 
indicated that they had learned about HPV either through the physician or the Internet.   
 Surprisingly, perceived social norms were considerably low for all participants 
prior to completing the intervention (2.21 out of 4 for the total sample), suggesting that 
participants perceived minimal social pressure to engage in the risk-reduction behaviors.  
Although changes in perceived social norms were noted among the intervention group, 
these changes were small, suggesting that the intervention did not influence perceived 
peer norms related to risk reduction.   
 T2 to T3:  Hypothesis 2.  Scores across all non-behavioral measures were 
examined from Time 2 to Time 3 to determine if there was a difference between groups 
in terms of maintenance of information.  As hypothesized, neither group demonstrated 
significant change in their scores from T2 to T3.  Given that the intervention group 
showed a significant increase from T1 to T2, and from T1 to T3, this suggests that 
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participants in the intervention condition maintained the information provided in the 
intervention over a one-month period even though there may have been some regression 
to the mean at T3.   
 T1 to T3:  Hypothesis 3.  To determine the longer-term effects of the intervention, 
scores across all non-behavioral measures were compared from Time 1 to Time 3.  As 
hypothesized, participants in the intervention condition continued to demonstrate 
significantly higher knowledge scores one-month post-intervention compared to the 
control group.  Similarly, participants’ intentions to engage in the targeted behaviors were 
higher after the intervention as compared to the control group, and this change was 
maintained one-month post-intervention.  However, while the intervention’s impact was 
notable, the changes were less substantial than they were at Time 2, suggesting that the 
impact of the intervention may have degraded over time.   
 Consistent with the findings from T1 to T2, changes in perceived social norms, 
attitudes towards engaging in the targeted behaviors, and perceived behavioral control for 
the intervention were not significant.  Given the intervention’s failure to initiate 
significant change from T1 to T2, it is not surprising that the change in these factors was 
not apparent one-month after the intervention.   
Behavioral Indicators: T1 to T3 
 Hypothesis 4.  Changes in risk reduction and prevention behaviors from T1 to T3 
were compared to determine the impact of the intervention on behavioral change.  The 
intervention was unsuccessful in initiating significant change for most of the risk-
reduction behaviors.  The only significant changes in the behaviors were seen in the HPV 
information- seeking and, interestingly, in HIV testing behavior.  While these behaviors 
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may not be direct methods of HPV prevention, research suggests that these are important 
steps to risk reduction (Jemmott & Jemmott, 2000; Lambert, 2001; McCree et al., 2007).  
Small, but not significant effects were noted in several risk-reduction behaviors.  For 
example, participants in the intervention condition had fewer sex partners as compared to 
the control condition when comparing the month prior to the intervention to the month 
following the intervention.  Similarly, participants were more likely to talk with vaginal 
and oral sex partners about STIs following the intervention.  Participants were also more 
likely to use barrier contraceptives after the intervention, regardless of their relationship 
status and use of hormonal contraceptives.  These conclusions must be interpreted with 
caution given the small effect size.  Unfortunately, the small sample size prohibited a 
meaningful analysis.  A number of participants had either not engaged in a sexual risk 
behavior to notice a reduction (e.g., anal sex) or had already engaged in the risk-reduction 
behavior (e.g., received Pap smear).  Perhaps, with a larger sample size and, possibly, a 
greater time period between the intervention and follow-up, a greater effect of the 
intervention would be detected.   
However, on a positive note, these findings do provide some empirical support for 
a brief one-time educational intervention in reducing the risk of an HPV infection.  
Measurable improvements in HPV knowledge and in intentions to engage in risk-
reduction behaviors were seen and these changes were maintained at one-month follow-
up.  Modest increases in attitudes toward risk-reduction behaviors, subjective norms, and 
related perceived behavioral control were obtained immediately after the intervention, but 
not at follow-up. Pre-existing levels of attitudes and perceived behavioral control with 
respect to the risk-reduction behaviors were high, limiting the ability to detect an effect of 
46 
 
the intervention.  Interestingly, pre-existing perceived peer norms related to risk 
reduction were low and remained relatively low for both groups; this suggests that 
participants perceived little peer pressure to engage in behaviors associated with reduced-
risk for HPV infection.   
Implications 
The intervention was a single-session intervention lasting for one hour.  Given the 
complexity of the thoughts and behaviors associated with sexual risk reduction, a more 
intensive program consisting of a longer session or multiple sessions may be advisable.  
By doing so, a greater level of measurable change that is maintained for longer periods of 
time may be possible.  Further, while the intervention incorporated skills-based 
components, there was little opportunity for participants to practice those skills in the 
intervention.  Future interventions should place greater emphasis on the practice of the 
skills (Brawner et al., 2012) such as role-playing, sex refusal, or condom purchase and 
negotiation (Dworkin, Exner, Melendez, Hoffman, & Ernhhardt, 2006; Wingood & 
DiClemente, 1996).  Additionally, finding ways to increase the ability to address factors 
such as perceived social norms is an important and complicated area (Brawner et al., 
2012).  Perhaps, having participants engage in their own data collection regarding options 
for reducing risk with their peers between sessions may be beneficial to assist in building 
more realistic and positive perceptions of the social pressure to engage in risk-reduction 
behaviors (Kirby et al., 2004).  Alternative suggestions included having naturally formed 
peer groups complete the intervention together to increase group norms (Stanton et al., 
1996) or have peer facilitators lead the intervention (Coyle et al., 2001).      
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Similarly, by incorporating a more CBT-based approach to the interventions in 
which participants are encouraged to practice the desired behaviors and record their 
efforts between sessions may beneficial (Farrell et al., 2008).  This would allow 
participants to discuss the challenges they met when attempting to engage in the desired 
behaviors.  Intervention facilitators could then encourage the group to problem-solve the 
ways to address the challenges as a group.  By doing so, participants’ attitudes, 
intentions, and perceived control for the targeted behaviors may be enhanced above and 
beyond what is possible in a single session intervention.      
Additionally, given the brief nature of the intervention, participants may have felt 
less comfortable clarifying misconceptions in the group format.  Therefore, interventions 
in which the group meets for multiple sessions may improve that comfort by increasing 
group members’ familiarity and engagement (MacKenzie & Livesly, 1983).  As a result, 
participants’ likelihood of asking for more specific clarification based on their needs may 
increase.   
Another suggested method for increasing effectiveness and participant comfort 
that might also be more cost and time efficient is an interactive, Internet-delivered 
intervention.  The Internet is readily being used for information gathering among older 
adolescents.   It is often the leading source of information due to ease of access, 
anonymity and affordability (Goldman & Bradley, 2001; Lu, 2009; Williams & Bonner, 
2006).  In fact, many individuals have indicated a preference for the Internet compared to 
health care providers as a source of health information, particularly information about 
sexual health and practices (Lu, 2009).  Females, in particular, have a greater tendency to 
seek out health information online compared to men (Gilbert, Temby, & Rogers, 2005).  
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Similar to the procedures utilized in this study, the Internet is being used to collect data 
regarding sexual health behavior (Herbenick et al., 2010a; Reece et al., 2010).  A 
growing area of interest in the field of STI risk reduction is the use of Internet delivered 
interventions.  Research has shown that the Internet is considered to be a useful and 
efficient method of intervention and information delivery by both participants and 
providers (Goldman & Bradley, 2001; Lu, 2009; Pequegnat et al., 2006; Rhodes et al., 
2003).  Further, because online interventions are more cost-efficient (Williams& Bonner, 
2006), yield more reliable data (Chiasson et al., 2006; Kissinger et al., 1999; Pequegnat et 
al., 2007; Zenilman, 2005), and are accessible by a wide audience (Chiasson et al., 2006; 
Goldman & Bradley, 2001; Pequegnat et al., 2007; Rhodes et al., 2010), they hold great 
promise in the field of health promotion.   
The current findings do suggest that a single-session educational intervention can 
produce measurable improvements in HPV knowledge and in intentions to engage in 
sexual risk reduction, as well as increased HPV information-seeking and HIV testing, and 
that these changes can be maintained over a one-month interval.  Briefer increases in 
subjective norms, risk-reduction attitudes, and perceived behavioral control were also 
obtained.   
Therefore, transferring the intervention used in this study into an Internet-
delivered group intervention, in which individuals can participate from the privacy of 
their home is a possible next step.  By developing the intervention into an Internet-
delivered product, a number of the present study’s limitations might be addressed.  Ease 
of access should result in a greater participant pool along with the ability to increase the 
intervention length without additional constraints.  Most importantly, it may also permit 
49 
 
greater participant comfort and engagement, thereby increasing the impact on risk-
reduction behaviors.  Similarly, there are greater opportunities for perceived social 
influence such as the use of peer facilitators or online bulletin boards in which peers are 
encouraged to engage in discussions regarding risk-reduction behaviors.   
Of course, this modality presents challenges of its own, including higher expected 
attrition rates (Bull, McFarlane, & King, 200), limited points of contact between the 
researchers and participants (Bull, Lloyd, Rietmeijer, & McFarlane, 2004) along with 
confounding variables such as the assessment and intervention environment (e.g., lab 
versus home), the content and level of interaction with the intervention, and sampling 
bias.   As with every area of research, careful consideration on behalf of the researchers is 
a must in order to reduce the impact of those challenges.   
Limitations  
 Given the exploratory nature of the study, there are several limitations in the 
present study.  First and foremost is the sample size.  Although the sample size for Part 1 
was adequate, 13.3% of all participants (18.9% from the control group, 6.4% from the 
intervention group) did not return for the one month follow-up.  As noted in previous 
research of comparable studies (Kamb et al., 1998; Petersen et al., 2007; Robin et al., 
2004), the overall rate of attrition (13.3%) and the control group rate of attrition (18.9%) 
were expected.  What was not anticipated was the low rate among the intervention group.  
However, the interactional nature of the intervention, along with facilitator differences 
(e.g., principle investigator facilitated the intervention while either the principal 
investigator or the research assistant facilitated the control) compared to the control could 
explain the differential attrition.  What was not anticipated was the additional loss of 
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participants based on exclusion-criteria (e.g., sexual history and/or age), suggesting that 
the screening measures used in the online sampling database were insufficient such that 
certain participants who were ineligible based on exclusion criteria were able to sign up 
for and complete the study.   
Unfortunately, the limited number of participants prevented certain items from 
being analyzed (e.g., anal sex risk-reduction behaviors; same-sex risk-reduction 
behaviors) and, perhaps, muddled the available results.  Thus, the strength of the 
conclusions is minimal. In order to ensure proper analysis of all variables of interest, 
oversampling in future studies is recommended.  Lastly, the intervention focused on HPV 
risk reduction among women.  Given the growing rate of HPV and HPV-associated 
cancers among men (CDC, 2012b) and similar reported barriers to vaccine use for men 
(Paul et al., 2013), future research examining the effectiveness of an HPV intervention 
developed for men is warranted.   
Conclusion 
The study was designed to assist in the field of risk reduction in order to diminish 
the risk of HPV infection for college-aged females (Bennett & Hodgson, 1992).  
Consistent with other risk-reduction interventions, the aim was to positively impact 
factors related to risk reduction (e.g., knowledge, intentions, attitudes, perceived social 
norms, perceived behavioral control) while simultaneously promoting risk-reduction 
behaviors.  Despite a number of limitations, the study demonstrated that a single-session 
educational intervention guided by the principles of TPB (Ajzen, 1991) and previous 
sexual risk-reduction research can be at least partially efficacious in reducing the risk of 
HPV infection among college-aged females.  However, partial efficacy is not true success 
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in the field of risk reduction.  Given the ubiquitous nature of HPV, the low rates of 
vaccination, and the limited ability of current vaccines to prevent all types of high-risk 
HPV, further research to determine more effective methods of HPV risk reduction is 
warranted.  Further research is indicated to not only reduce the risk of an HPV infection 
but also to aid in early detection and treatment of HPV infection to reduce the risk of the 
HPV-related cancers among women.    
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Table 10. Pearson Chi-Square results for positive change on dichotomous behavioral 
variables from T1 to T3.   
   Intervention  Control  
χ2(N) 
   Change a (%)  Change a (%)  
HPV Vaccine    4(11.1)  2(5.4)  0.79(73) 
HPV Info   13(68.4)  5(31.3)  4.80*(35) 
Pap Smear   2(13.3)  1(7.1)  .30(29) 
HIV Test   7(30.4)  0(0)  9.23**(49) 
STIs Test   5(26.3)  2(12.5)  1.04(35) 
   Change b (%)  Change b (%)  χ2(N) 
Smoke   1 (16.7)  1(12.5)  .05(14) 
Note. *p < .05. ** p < .01. aParticipants who changed (change=1, no change=0) from No 
(1) to Yes (0) at T3 out of participants who said No (1) at T1.  bParticipants who changed 
(change=1, no change=0) from Yes (1) to No (0) at T3 out of participants who said Yes 
(1) at T1. 
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APPENDIX A:  INTERVENTION OUTLINE 
 
 
1. Introduction 
a. Confidentiality 
b. Group norms/expectations 
2. HPV Factual Information (knowledge, attitudes)   
a. Types of HPV 
i. Focus on ‘high risk’ types 
b. Impact of infection 
i. Body’s natural response 
ii. HPV-related cancers 
c. Incidence and Prevalence of HPV 
i. Focus on adolescents and college women 
d. Incidence of HPV-related cancers 
3. Risk factors for HPV exposure (knowledge, attitudes) 
a. Sexual behaviors 
4. Risk factors for serious HPV infection/pre-cancer (knowledge, attitudes) 
a. Lifestyle & health behaviors 
5. HPV risk reduction (knowledge, attitudes) 
a. Sexual behaviors 
b. Lifestyle & health behaviors 
c. Infection management (if already infected) 
6. HPV detection, diagnosis, and treatment (knowledge, attitudes) 
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7. Addressing perceived obstructions to behavioral activation (perceived behavioral 
control) 
a. Acknowledgement and normalization of perceived barriers (subjective 
norms, perceived behavioral control) 
b. Societal expectations/endorsement of target behaviors (subjective norms) 
c. Importance of engaging in risk reduction and prevention behaviors 
(attitudes) 
8. Skills building and encouragement for behavioral activation (subjective norms, 
perceived behavioral control) 
a. Decision-making strategies 
i. Barrier contraceptive use  
b. Communication strategies 
i. Talking with partners regarding contraceptive use and STI testing 
history 
ii. Disclosing sexual history  
iii. Purchasing barriers contraceptives 
c. Problem-solving strategies 
i. Dealing with partner objections  
ii. Locating health providers and ensuring insurance coverage 
iii. Locating and purchasing barriers contraceptives 
iv. Proper use of barrier contraceptives 
9. Intervention Wrap-Up 
a. Additional questions/concerns 
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APPENDIX B:  PART 1 AND 2 STUDY DESCRIPTION FOR UNCC 
SONASYSTEMS® 
 
 
Study Name Behaviors - Part One 
Abstract Two part study. This is PART 1.Part 1 takes place in Psychology Lab (120 
minutes, 2 credits) Part 2 is completed online (45 minutes, 1 credit + entry 
into drawing to win one of ten $50 Target gift certificates) 
Description This is a two-part study focusing on the sexual health practices of college 
women aged 18 to 24 who have engaged in anal, oral, and/or vaginal sex 
in the past month. For Part 1, you will be asked to come to the Psychology 
Lab and fill out a computerized survey relating to sexual health 
knowledge, practices, and beliefs. These questions are sensitive in nature 
and all possible steps to protect the confidentiality of the information will 
be taken.  You will provide data using computer-based surveys using a 
unique code known only to you.  With the use of the code, the data will 
remain anonymous to everyone except you.  The surveys are encrypted 
using SSL.   Data will be stored in a password-protected folder on a 
password-protected network drive accessible only by the principal 
investigator and the faculty members listed on the IRB protocol.  Signed 
informed consent forms will be kept in a locked file cabinet and will be 
stored completely separate and apart from any data.   These documents 
will be shredded upon completion of the study.  You will then participate 
in one of two educational programs with a maximum of 8 other 
participants.  Based on your group assignment, you may participate in an 
educational program about study skills or you may participate in an 
educational program about health and sexual relationships.   After the 
educational program, you will be asked to complete another survey based 
on your experience with the program.  You must sign up separately for 
Part 2 (STI-Part Two). For Part 2, you will be emailed a link 28 days after 
completing Part 1. This link will direct you to a survey focusing on 
aspects of sexual health in relation to STIs. Your participation in Part 1 of 
this project will take approximately 2 hours. Part 2 will take 
approximately 45 minutes. Part 1 and Part 2 of the study will be conducted 
one month apart. The benefits of participation in this study are the 
accumulation of 2 Research Requirement points at completion of Part 1 
and 1 point at completion of Part 2, totaling 3 points towards the Research 
Requirement points for UNCC Introductory Psychology. Additionally, 
upon completion of Part 2 of the study, you will be entered into drawing to 
win one of ten $50 gift certificates.  
 
 
Study Name Behaviors - Part Two 
Abstract THIS IS PART 2 of the two-part Behaviors Study. You must wait 28 days 
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after completing Part 1. Part 2 is completed online (45 minutes, 1 credit + 
entry into drawing to win one of ten $50 gift certificates), resulting in a 
one in twelve chance of winning a gift certificate 
Description This is the second part of the two part study focusing on the sexual health 
practices of college women aged 18 to 24 who have engaged in anal, oral, 
and/or vaginal sex in the past month. For Part 2, you will be emailed a link 
28 days after completing Part 1. This link will direct you to a survey 
focusing on aspects of sexual health in relation to STIs. Part 2 will take 
approximately 45 minutes. These questions are sensitive in nature and all 
possible steps to protect the confidentiality of the information will be 
taken.  You will provide data using computer-based surveys using a 
unique code known only to you.  With the use of the code, the data will 
remain anonymous to everyone except you.  The surveys are encrypted 
using SSL.   Data will be stored in a password-protected folder on a 
password-protected network drive accessible only by the principal 
investigator and the faculty members listed on the IRB protocol.  Signed 
informed consent forms will be kept in a locked file cabinet and will be 
stored completely separate and apart from any data.   These documents 
will be shredded upon completion of the study.     
Part 1 and Part 2 of the study will be conducted one month apart. You will 
receive 1 point at completion of Part 2 and will be entered into a drawing 
to win one of ten $50 Target gift certificates. 
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APPENDIX C:  PRE-SCREEN QUESTIONS FOR UNCC SONASYSTEMS® 
 
 
Underlined items indicate eligibility assuming all red items selected.  
1. Are you female? 
a. Yes 
b. No 
2. Have you engaged in oral, anal, and/or vaginal sex in the past month? 
a. Yes 
b. No 
3. Have you received the HPV vaccine? 
a. Yes 
b. No 
4. Are you between 18-24 years old? 
a. Yes 
b.   No 
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APPENDIX D:  PRE-TEST (T1) AND FOLLOW-UP (T3) MEASURES 
 
 
1) Please enter the first three letters of your middle name, the first three letters of your 
birth city, and the first three letters of you mother's maiden name. For example, my 
name is Jocelyn Brineman Sweeney, I was born in Stuttgart, Germany, and my 
mother's name before she was married was Carolyn Terri Denniston. Therefore, I 
would enter BriStuDen 
 
Demographics 
Please answer the following questions 
 
2) Age 
 
3) Race 
• American-Indian/Alaska Native 
• Asian-American/Asian Origin/Pacific Islander 
• African-American/Non-Hispanic Black/African Origin 
• White/European Origin/Caucasian 
• Hispanic/Latino/a 
• Bi-racial/Multi-racial 
• Other: 
 
4) Year in School 
• Freshman 
• Sophomore 
• Junior 
• Senior 
• Post-Bach 
• Graduate 
• Other: 
 
5) What is your relationship status? 
• Single and not dating 
• Single but dating one or more people 
• In a relationship but not living together 
• Living with a partner but not married 
• Married 
 
6) How long have you been in a relationship? 
• Less than 1 month 
• Between 1 and 3 months 
• Between 4 and 6 months 
• Between 7 months and a year 
• Over a year 
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7) Sexual Orientation 
• Heterosexual 
• Lesbian 
• Bisexual 
• Other: 
  
81 
 
Sexual Health and History Survey 
Please answer the following questions 
 
8) Have you ever had vaginal sex with a person of the opposite sex? 
• Yes 
• No 
 
9) How many opposite-sex vaginal sex partners have you had in your lifetime? 
 
10) How old were you when you first had vaginal sex with a partner of the opposite sex? 
• Under 12 
• Between 12 and 15 
• Between 16 and 18 
• Between 19 and 21 
• Over 21 
 
11) Have you had vaginal sex with a person of the opposite sex in the past 1 month? 
• Yes 
• No 
 
12) How many opposite-sex vaginal sex partners have you had in the past month? 
 
13) In the past 1 month, how often did you discuss sexually transmitted infections 
(STIs)/human immunodeficiency virus (HIV) with opposite-sex vaginal sex partners? 
• Never 
• Rarely 
• Sometimes 
• Often 
• Always 
 
14) What factors, if any, prohibited discussion with your opposite-sex vaginal sex 
partners about STIs/HIV? 
• Not applicable 
• I didn't want to 
• My partner(s) didn't want to 
• Other: 
 
15) Approximately how many times have you had vaginal sex with opposite-sex partners 
in the past 1 month? 
 
16) How often did you use a barrier contraceptive (e.g., condoms) during vaginal sex 
with opposite-sex partners in the past 1 month? 
• Never 
• Rarely 
• Sometimes 
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• Often 
• Always 
 
17) What prevented you from using barrier contraceptives during vaginal sex with 
opposite-sex partners in the past 1 month? 
• Not applicable 
• I didn't want to 
• My partner(s) didn't want to 
• Other: 
 
18) In the past 1 month, how often did you use alcohol or drugs when you had vaginal 
sex with an opposite-sex partner? 
• Never 
• Rarely 
• Sometimes 
• Often 
• Always 
 
19) Have you ever had anal sex with a person of the opposite sex? 
• Yes 
• No 
 
20) How many opposite-sex anal sex partners have you had in your lifetime? 
 
21) How old were you when you first had anal sex with a partner of the opposite sex? 
• Under 12 
• Between 12 and 15 
• Between 16 and 18 
• Between 19 and 21 
• Over 21 
 
22) Have you had anal sex with a person of the opposite sex in the past 1 month? 
• Yes 
• No 
 
23) How many opposite-sex anal sex partners have you had in the past 1 month? 
 
24) In the past 1 month, how often did you discuss sexually transmitted infections 
(STIs)/human immunodeficiency virus (HIV) with opposite-sex anal sex partners? 
• Never 
• Rarely 
• Sometimes 
• Often 
• Always 
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25) What factors, if any, prohibited you from talking with your opposite-sex anal sex 
partners about STIs/HIV? 
• Not applicable 
• I didn't want to 
• My partner(s) didn't want to 
• Other: 
 
26) Approximately how many times have you had anal sex with opposite-sex partners in 
the past 1 month? 
 
27) How often did you use a barrier contraceptive (e.g., condoms) during anal sex wtih 
opposite-sex partners in the past 1 month? 
• Never 
• Rarely 
• Sometimes 
• Often 
• Always 
 
28) What prevented you from using barrier contraceptives during anal sex with opposite-
sex partners in the past 1 month? 
• Not applicable 
• I didn't want to 
• My partner(s) didn't want to 
• Other: 
 
29) In the past 1 month, how often did you use alcohol or drugs when you had anal sex 
with opposite-sex partners? 
• Never 
• Rarely 
• Sometimes 
• Often 
• Always 
 
30) Have you ever had oral sex with a person of the opposite sex? 
• Yes 
• No 
 
31) How many opposite-sex oral sex partners have you had in your lifetime? 
 
32) How old were you when you first had oral sex with a partner of the opposite-sex? 
• Under 12 
• Between 12 and 15 
• Between 16 and 18 
• Between 19 and 21 
• Over 21 
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33) Have you had oral sex with a person of the opposite sex in the past 1 month? 
• Yes 
• No 
 
34) How many opposite-sex oral sex partners have you had in the past 1 month? 
 
35) In the past 1 month, how often did you discuss sexually transmitted infections 
(STIs)/human immunodeficiency virus (HIV) with new opposite-sex oral sex 
partners? 
• Never 
• Rarely 
• Sometimes 
• Often 
• Always 
 
36) What prevented you from talking with your opposite-sex oral sex partners about 
STIs/HIV? 
• Not applicable 
• I didn't want to 
• My partner(s) didn't want to 
• Other: 
 
37) Approximately how many times have you had oral sex with opposite-sex partners in 
the past 1 month? 
 
38) How often did you use a barrier contraceptive (e.g., condoms) during oral sex with 
opposite-sex partners in the past 1 month? 
• Never 
• Rarely 
• Sometimes 
• Often 
• Always 
 
39) What prevented you from using barrier contraceptives during oral sex with opposite-
sex partners in the past 1 month? 
• Not applicable 
• I didn't want to 
• My partner(s) didn't want to 
• Other: 
 
40) In the past 1 month, how often did you use alcohol or drugs when you had oral sex 
with an opposite-sex partner? 
• Never 
• Rarely 
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• Sometimes 
• Often 
• Always 
 
41) Have you ever had vaginal sex with a person of the same sex? 
• Yes 
• No 
 
42) How many same-sex vaginal sex partners have you had in your lifetime? 
 
43) How old were you the first time you had vaginal sex with a partner of the same-sex? 
• Under 12 
• Between 12 and 15 
• Between 16 and 18 
• Between 19 and 21 
• Over 21 
 
44) Have you had vaginal sex with a person of the same sex in the past 1 month? 
• Yes 
• No 
 
45) How many same-sex vaginal sex partners have you had in the past 1 month? 
 
46) In the past 1 month, how often did you discuss sexually transmitted infections 
(STIs)/human immunodeficiency virus (HIV) with same-sex vaginal sex partners? 
• Never 
• Rarely 
• Sometimes 
• Often 
• Always 
 
47) What factors, if any, prohibited discussion with your same-sex vaginal sex partners 
about STIs/HIV? 
• Not applicable 
• I didn't want to 
• My partner(s) didn't want to 
• Other: 
 
48) Approximately how many times have you had vaginal sex with same-sex partners in 
the past 1 month? 
 
49) How often did you use a barrier contraceptive (e.g., condoms) during vaginal sex 
with same-sex partners in the past 1 month? 
• Never 
• Rarely 
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• Sometimes 
• Often 
• Always 
 
50) What prevented you from using barrier contraceptives during vaginal sex with same-
sex partners in the past 1 month? 
• Not applicable 
• I didn't want to 
• My partner(s) didn't want to 
• Other: 
 
51) In the past 1 month, how often did you use alcohol or drugs when you had vaginal 
sex with same-sex partners? 
• Never 
• Rarely 
• Sometimes 
• Often 
• Always 
 
52) Have you ever had oral sex with a person of the same sex? 
• Yes 
• No 
 
53) How many same-sex oral sex partners have you had in your lifetime? 
 
54) How old were you when you first had oral sex with a partner of the same sex? 
• Under 12 
• Between 12 and 15 
• Between 16 and 18 
• Between 19 and 21 
• Over 21 
 
55) Have you had oral sex with a person of the same sex in the past 1 month? 
• Yes 
• No 
 
56) How many same-sex oral sex partners have you had in the past 1 month? 
 
57) In the past 1 month, how often did you discuss sexually transmitted infections 
(STIs)/human immunodeficiency virus (HIV) with same-sex oral sex partners? 
• Never 
• Rarely 
• Sometimes 
• Often 
• Always 
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58) What prevented you from talking with your same-sex oral sex partners about 
STIs/HIV? 
• Not applicable 
• I didn't want to 
• My partner(s) didn't want to 
• Other: 
 
59) Approximately how many times have you had oral sex with same-sex partners in the 
past 1 month? 
 
60) How often did you use a barrier contraceptive (e.g., condoms) during oral sex with 
same-sex partners in the past 1 month? 
• Never 
• Rarely 
• Sometimes 
• Often 
• Always 
 
61) What prevented you from using barrier contraceptives during oral sex with same-sex 
partners in the past 1 month? 
• Not applicable 
• I didn't want to 
• My partner(s) didn't want to 
• Other: 
 
62) In the past 1 month, how often did you use alcohol or drugs when you had oral sex 
with a same-sex partner? 
• Never 
• Rarely 
• Sometimes 
• Often 
• Always 
 
63) Have you received one or more human papillomavirus (HPV) vaccines? 
• Yes 
• No 
 
64) Have you sought out any information on HPV? 
• Yes 
• No 
 
65) What sources did you use? 
• Internet 
• Doctor 
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• Friend 
• Partner 
• Parent 
• Professor 
• Other: 
 
66) Have you ever had a Pap smear? 
• Yes 
• No 
 
67) Have you ever had an abnormal Pap smear? 
• Yes 
• No 
 
68) Have you ever been tested for human immunodeficiency virus (HIV)? 
• Yes 
• No 
 
69) Do you currently smoke cigarettes? 
• Yes 
• No 
 
70) Do you use hormonal contraceptives (birth control)? 
• Yes 
• No 
 
71) Are you trying to get pregnant? 
• Yes 
• No 
 
72) Have you ever been tested for a sexually transmitted infection (STI)? 
• Yes 
• No 
 
73) Have you ever been diagnosed with an STI? 
• Yes 
• No 
74) Which STIs have you received a diagnosis for? 
• Herpes 
• Gonorrhea 
• Human papillomavirus (HPV) 
• Genital warts 
• Chlamydia 
• Syphilis 
• Other: 
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HPV Knowledge Scale 
Please mark the following statements about HPV (human papillomavirus) as True, False, 
or Not Sure 
 
75) There are many types of HPV 
• True 
• False 
• Not Sure 
 
76) HPV causes HIV/AIDS 
• True 
• False 
• Not Sure 
 
77) Antibiotics can cure HPV 
• True 
• False 
• Not Sure 
 
78) You can always tell when someone else has HPV 
• True 
• False 
• Not Sure 
 
79) HPV causes abnormal Pap smears 
• True 
• False 
• Not Sure 
 
80) Only women get HPV 
• True 
• False 
• Not Sure 
 
81) HPV causes herpes 
• True 
• False 
• Not Sure 
 
82) HPV affects your ability to get pregnant 
• True 
• False 
• Not Sure 
 
83) HPV is a virus 
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• True 
• False 
• Not Sure 
 
84) A vaccine may prevent HPV 
• True 
• False 
• Not Sure 
 
85) HPV causes genital warts 
• True 
• False 
• Not Sure 
 
86) You can have HPV without knowing it 
• True 
• False 
• Not Sure 
 
87) HPV can be cured 
• True 
• False 
• Not Sure 
 
88) HPV is spread on toiled seats 
• True 
• False 
• Not Sure 
 
89) HPV is sexually transmitted infection 
• True 
• False 
• Not Sure 
 
90) HPV causes cervical cancer 
• True 
• False 
• Not sure 
 
91) You can get HPV through poor personal hygiene 
• True 
• False 
• Not Sure 
 
92) Even if you do not see a wart, you can transmit HPV 
91 
 
• True 
• False 
• Not Sure 
 
93) You can decrease the chance of transmitting warts during intercourse 
• True 
• False 
• Not Sure 
 
94) Using a condom will decrease the chance of transmitting warts 
• True 
• False 
• Not Sure 
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Future Intentions Survey 
Please respond to the following questions 
 
95) To what degree do you intend to reduce your risk of exposure to HPV (human 
papillomavirus)? 
• I do not intend to 
• Undecided 
• I intend to 
 
96) To what degree do you intend to use condoms wtih a sexual partner in the next 
month? 
• I do not intend to 
• Undecided 
• I intend to 
 
97) To what degree do you intend to reduce the number of new sexual partners in the 
next month? 
• I do not intend to 
• Undecided 
• I intend to 
 
98) To what degree do you intend to engage in unprotected vaginal sex in the next 
month? 
• I do not intend to 
• Undecided 
• I intend to 
 
99) To what degree do you intend to engage in unprotected anal sex in the next month? 
• I do not intend to 
• Undecided 
• I intend to 
 
100) To what degree do you intend to engage in unprotected oral sex in the next month? 
• I do not intend to 
• Undecided 
• I intend to 
 
101) To what degree do you intend to get tested for sexually transmitted infections (STIs) 
in the next month? 
• I do not intend to 
• Undecided 
• I intend to 
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102) To what degree do you intend to discuss sexually transmitted infections 
(STIs)/human immunodeficiency virus (HIV) with your sexual partner(s) in the next 
month? 
• I do not intend to 
• Undecided 
• I intend to 
 
103) To what degree do you intend to receive a Pap smear in the next 12 months? 
• I do not intend to 
• Undecided 
• I intend to 
 
104) To what degree do you intend to receive at least one of the human papillomavirus 
(HPV) vaccines in the next 12 months? 
• I do not intend to 
• Undecided 
• I intend to 
• I've already started/completed the HPV vaccine series 
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Attitudes Towards Intentions 
Please respond to the following questions. 
 
105) Reducing my risk of exposure to HPV (human papillomavirus) is 
• Beneficial 
• Neither beneficial nor harmful 
• Harmful 
 
106) Reducing my risk of exposure to HPV is 
• Good 
• Neither good nor bad 
• Bad 
 
107) Using condoms with a partner is 
• Unpleasant 
• Neither pleasant nor unpleasant 
• Pleasant 
 
108) Using condoms with a partner is 
• Beneficial 
• Neither beneficial nor harmful 
• Harmful 
 
109) Reducing the number of new sex partners I have is 
• Good 
• Neither good nor bad 
• Bad 
 
110) Reducing the number of new sex partners I have is 
• Worthless 
• Neither worthless nor useful 
• Useful 
 
111) Engaging in unprotected vaginal sex can be 
• Harmful 
• Neither harmful nor beneficial 
• Beneficial 
 
112) Engaging in unprotected vaginal sex can be 
• Good 
• Neither good nor bad 
• Bad 
 
113) Engaging in unprotected anal sex can be 
• Harmful 
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• Neither harmful nor beneficial 
• Beneficial 
 
114) Engaging in unprotected anal sex can be 
• Good 
• Neither good nor bad 
• Bad 
 
115) Engaging in unprotected oral sex can be 
• Harmful 
• Neither harmful nor beneficial 
• Beneficial 
 
116) Engaging in unprotected oral sex can be 
• Good 
• Neither good nor bad 
• Bad 
 
117) Getting tested for sexually transmitted infections (STIs) is 
• Worthless 
• Neither worthless nor useful 
• Useful 
 
118) Getting tested for sexually transmitted infections (STIs) is 
• Harmful 
• Neither harmful nor beneficial 
• Beneficial 
 
119) Discussing STIs/HIV with your sexual partner(s) is 
• Worthless 
• Neither worthless nor useful 
• Useful 
 
120) Discussing STIs/HIV with your sexual partner(s) is 
• Harmful 
• Neither harmful nor beneficial 
• Beneficial 
 
121) Receiving a Pap smear is 
• Good 
• Neither good nor bad 
• Bad 
 
122) Receiving a Pap smear is 
• Harmful 
96 
 
• Neither harmful nor beneficial 
• Beneficial 
 
123) Receiving the HPV vaccines is 
• Harmful 
• Neither harmful nor beneficial 
• Beneficial 
 
124) Receiving the HPV vaccines is 
• Worthless 
• Neither worthless nor useful 
• Useful 
  
97 
 
Subjective Norms 
Please respond to the following questions 
 
125) I feel under social pressure to reduce my risk of exposure to HPV (human 
papillomavirus) 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
126) I feel under social pressure to use a condom with a partner 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
127) I feel under social pressure to reduce the number of new sex partners I have 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
128) I feel under social pressure to engage in unprotected vaginal sex 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
129) I feel under social pressure to engage in unprotected anal sex 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
130) I feel under social pressure to engage in unprotected oral sex 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
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131) I feel under social pressure to get tested for sexually transmitted infections (STIs) 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
132) I feel under social pressure to discuss STIs/HIV with sexual partners 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
133) I feel under social pressure to receive a Pap smear 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
134) I feel under social pressure to receive the HPV vaccines 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
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Perceived Behavioral Control 
Please respond to the following questions 
 
135) I am confident that I can reduce my risk of exposure to HPV (human 
papillomavirus) if I want to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
136) I am confident that I can use a condom with a sexual partner if I want to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
137) I am confident that I can reduce the number of new sexual partners I have if I want 
to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
138) I am confident that I can engage in unprotected vaginal sex if I want to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
139) I am confident that I can engage in unprotected anal sex if I want to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
140) I am confident that I can engage in unprotected oral sex if I want to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
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• Strongly Agree 
 
141) I am confident that I can get tested for sexually transmitted infections (STIs) if I 
want to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
142) I am confident that I can discuss STIs/HIV with sexual partners if I want to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
143) I am confident that I can receive a Pap smear if I want to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
144) I am confident that I can receive the HPV vaccines if I want to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
145) Whether or not I reduce my risk of exposure to HPV is entirely up to me 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
146) Whether or not I use a condom with a sexual partner is entirely up to me 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
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147) Whether or not I reduce the number of new sex partners I have is entirely up to me 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
148) Whether or not I engage in unprotected vaginal sex is entirely up to me 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
149) Whether or not I engage in unprotected anal sex is entirely up to me 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
150) Whether or not I engage in unprotected oral sex is entirely up to me 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
151) Whether or not I get tested for sexually transmitted infections (STIs) is entirely up 
to me 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
152) Whether or not I discuss STIs/HIV with sexual partners is entirely up to me 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
153) Whether or not I receive a Pap smear is entirely up to me 
• Strongly Disagree 
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• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
154) Whether or not I receive the HPV vaccines is entirely up to me 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
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APPENDIX E:  POST-TEST (T2) MEASURES  
 
 
1) Please indicate the topic of your educational intervention 
• A group discussion with the researcher, Jocelyn, about HPV 
• An online video about study skills 
 
2) Please enter the first three letters of your middle name, the first three letters of your 
birth city, and the first three letters of you mother's maiden name. For example, my 
name is Jocelyn Brineman Sweeney, I was born in Stuttgart, Germany, and my 
mother's name before she was married was Carolyn Terri Denniston. Therefore, I 
would enter BriStuDen 
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HPV Knowledge Scale 
Please mark the following statements about HPV (human papillomavirus) as True, False, 
or Not Sure 
 
3) There are many types of HPV 
• True 
• False 
• Not Sure 
 
4) HPV causes HIV/AIDS 
• True 
• False 
• Not Sure 
 
5) Antibiotics can cure HPV 
• True 
• False 
• Not Sure 
 
6) You can always tell when someone else has HPV 
• True 
• False 
• Not Sure 
 
7) HPV causes abnormal Pap smears 
• True 
• False 
• Not Sure 
 
8) Only women get HPV 
• True 
• False 
• Not Sure 
 
9) HPV causes herpes 
• True 
• False 
• Not Sure 
 
10) HPV affects your ability to get pregnant 
• True 
• False 
• Not Sure 
 
11) HPV is a virus 
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• True 
• False 
• Not Sure 
 
12) A vaccine may prevent HPV 
• True 
• False 
• Not Sure 
 
13) HPV causes genital warts 
• True 
• False 
• Not Sure 
 
14) You can have HPV without knowing it 
• True 
• False 
• Not Sure 
 
15) HPV can be cured 
• True 
• False 
• Not Sure 
 
16) HPV is spread on toiled seats 
• True 
• False 
• Not Sure 
 
17) HPV is sexually transmitted infection 
• True 
• False 
• Not Sure 
 
18) HPV causes cervical cancer 
• True 
• False 
• Not sure 
 
19) You can get HPV through poor personal hygiene 
• True 
• False 
• Not Sure 
 
20) Even if you do not see a wart, you can transmit HPV 
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• True 
• False 
• Not Sure 
 
21) You can decrease the chance of transmitting warts during intercourse 
• True 
• False 
• Not Sure 
 
22) Using a condom will decrease the chance of transmitting warts 
• True 
• False 
• Not Sure 
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Future Intentions Survey 
Please respond to the following questions 
 
23) To what degree do you intend to reduce your risk of exposure to HPV (human 
papillomavirus)? 
• I do not intend to 
• Undecided 
• I intend to 
 
24) To what degree do you intend to use condoms wtih a sexual partner in the next 
month? 
• I do not intend to 
• Undecided 
• I intend to 
 
25) To what degree do you intend to reduce the number of new sexual partners in the 
next month? 
• I do not intend to 
• Undecided 
• I intend to 
 
26) To what degree do you intend to engage in unprotected vaginal sex in the next 
month? 
• I do not intend to 
• Undecided 
• I intend to 
 
27) To what degree do you intend to engage in unprotected anal sex in the next month? 
• I do not intend to 
• Undecided 
• I intend to 
 
28) To what degree do you intend to engage in unprotected oral sex in the next month? 
• I do not intend to 
• Undecided 
• I intend to 
 
29) To what degree do you intend to get tested for sexually transmitted infections (STIs) 
in the next month? 
• I do not intend to 
• Undecided 
• I intend to 
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30) To what degree do you intend to discuss sexually transmitted infections 
(STIs)/human immunodeficiency virus (HIV) with your sexual partner(s) in the next 
month? 
• I do not intend to 
• Undecided 
• I intend to 
 
31) To what degree do you intend to receive a Pap smear in the next 12 months? 
• I do not intend to 
• Undecided 
• I intend to 
 
32) To what degree do you intend to receive at least one of the human papillomavirus 
(HPV) vaccines in the next 12 months? 
• I do not intend to 
• Undecided 
• I intend to 
• I've already started/completed the HPV vaccine series 
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Attitudes Towards Intentions 
Please respond to the following questions. 
 
33) Reducing my risk of exposure to HPV (human papillomavirus) is 
• Beneficial 
• Neither beneficial nor harmful 
• Harmful 
 
34) Reducing my risk of exposure to HPV is 
• Good 
• Neither good nor bad 
• Bad 
 
35) Using condoms with a partner is 
• Unpleasant 
• Neither pleasant nor unpleasant 
• Pleasant 
 
36) Using condoms with a partner is 
• Beneficial 
• Neither beneficial nor harmful 
• Harmful 
 
37) Reducing the number of new sex partners I have is 
• Good 
• Neither good nor bad 
• Bad 
 
38) Reducing the number of new sex partners I have is 
• Worthless 
• Neither worthless nor useful 
• Useful 
 
39) Engaging in unprotected vaginal sex can be 
• Harmful 
• Neither harmful nor beneficial 
• Beneficial 
 
40) Engaging in unprotected vaginal sex can be 
• Good 
• Neither good nor bad 
• Bad 
 
41) Engaging in unprotected anal sex can be 
• Harmful 
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• Neither harmful nor beneficial 
• Beneficial 
 
42) Engaging in unprotected anal sex can be 
• Good 
• Neither good nor bad 
• Bad 
 
43) Engaging in unprotected oral sex can be 
• Harmful 
• Neither harmful nor beneficial 
• Beneficial 
 
44) Engaging in unprotected oral sex can be 
• Good 
• Neither good nor bad 
• Bad 
 
45) Getting tested for sexually transmitted infections (STIs) is 
• Worthless 
• Neither worthless nor useful 
• Useful 
 
46) Getting tested for sexually transmitted infections (STIs) is 
• Harmful 
• Neither harmful nor beneficial 
• Beneficial 
 
47) Discussing STIs/HIV with your sexual partner(s) is 
• Worthless 
• Neither worthless nor useful 
• Useful 
 
48) Discussing STIs/HIV with your sexual partner(s) is 
• Harmful 
• Neither harmful nor beneficial 
• Beneficial 
 
49) Receiving a Pap smear is 
• Good 
• Neither good nor bad 
• Bad 
 
50) Receiving a Pap smear is 
• Harmful 
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• Neither harmful nor beneficial 
• Beneficial 
 
51) Receiving the HPV vaccines is 
• Harmful 
• Neither harmful nor beneficial 
• Beneficial 
 
52) Receiving the HPV vaccines is 
• Worthless 
• Neither worthless nor useful 
• Useful 
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Subjective Norms 
Please respond to the following questions 
 
53) I feel under social pressure to reduce my risk of exposure to HPV (human 
papillomavirus) 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
54) I feel under social pressure to use a condom with a partner 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
55) I feel under social pressure to reduce the number of new sex partners I have 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
56) I feel under social pressure to engage in unprotected vaginal sex 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
57) I feel under social pressure to engage in unprotected anal sex 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
58) I feel under social pressure to engage in unprotected oral sex 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
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59) I feel under social pressure to get tested for sexually transmitted infections (STIs) 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
60) I feel under social pressure to discuss STIs/HIV with sexual partners 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
61) I feel under social pressure to receive a Pap smear 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
62) I feel under social pressure to receive the HPV vaccines 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
  
114 
 
Perceived Behavioral Control 
Please respond to the following questions 
 
63) I am confident that I can reduce my risk of exposure to HPV (human papillomavirus) 
if I want to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
64) I am confident that I can use a condom with a sexual partner if I want to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
65) I am confident that I can reduce the number of new sexual partners I have if I want to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
66) I am confident that I can engage in unprotected vaginal sex if I want to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
67) I am confident that I can engage in unprotected anal sex if I want to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
68) I am confident that I can engage in unprotected oral sex if I want to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
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69) I am confident that I can get tested for sexually transmitted infections (STIs) if I want 
to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
70) I am confident that I can discuss STIs/HIV with sexual partners if I want to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
71) I am confident that I can receive a Pap smear if I want to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
72) I am confident that I can receive the HPV vaccines if I want to 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
73) Whether or not I reduce my risk of exposure to HPV is entirely up to me 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
74) Whether or not I use a condom with a sexual partner is entirely up to me 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
75) Whether or not I reduce the number of new sex partners I have is entirely up to me 
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• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
76) Whether or not I engage in unprotected vaginal sex is entirely up to me 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
77) Whether or not I engage in unprotected anal sex is entirely up to me 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
78) Whether or not I engage in unprotected oral sex is entirely up to me 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
79) Whether or not I get tested for sexually transmitted infections (STIs) is entirely up to 
me 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
80) Whether or not I discuss STIs/HIV with sexual partners is entirely up to me 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
81) Whether or not I receive a Pap smear is entirely up to me 
• Strongly Disagree 
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• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
 
82) Whether or not I receive the HPV vaccines is entirely up to me 
• Strongly Disagree 
• Disagree 
• Undecided 
• Agree 
• Strongly Agree 
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APPENDIX F:  INFORMED CONSENT FORM 
 
 
 
 
 UNCC Department of Psychology   
9201 University City Boulevard 
 Charlotte, NC  28223 
 
Informed Consent for 
Behaviors Part 1 and Part 2 
 
Project Title and Purpose: 
You are invited to participate in a research study titled Behaviors.  This is a two-part study 
focusing on the sexual health practices of college women aged 18 to 24 who have engaged in 
anal, oral, and/or vaginal sex in the past month.   
Investigator(s): 
This study is being conducted by Jocelyn Sweeney as well as Dr. Rick McAnulty of the UNCC 
Psychology Department.  Anam Barakzai will assist with data collection. 
 
Description of Participation: 
For Part 1, you will be asked to fill out a computerized survey relating to sexual health 
knowledge, practices, and beliefs.  More specifically, you will be asked about your experience 
with anal, oral, and vaginal sex, condom use, along with questions about sexually transmitted 
infections (STI) and other related behaviors.  You will then participate in one of two educational 
programs with a maximum of 8 other participants. Based on your group assignment, you may 
participate in an educational program about study skills or you may participate in an educational 
program about health and sexual relationships.  After the educational program, you will be asked 
to complete another survey based on your experience with the program.  For Part 2, you will be 
asked to complete another survey once again focusing on aspects of sexual health in relation to 
STIs.  This survey will be completed online from your own computer or a computer of your 
choice.  Your email addresses will collected through the UNCC SonaSystem® and you will be 
emailed with information regarding how to access the survey 28 days after completing Part 1.  
The information gathered in the surveys is sensitive in nature and all possible steps to protect the 
confidentiality of the information will be taken.   
 
Length of Participation 
Your participation in Part 1 of this project will take approximately 2 hours.  During this time you 
will be completing two surveys and participating in one of two educational programs.  The first 
survey is 154 items and will take approximately 35 minutes to complete.  The educational 
programs will take approximately 45 minutes to 1 hour to complete.  The second survey is 81 
items and will take approximately 20 minutes to complete.   For Part 2, you will also be 
completing a 154 item survey which will take you approximately 35 minutes.  Part 1 and Part 2 of 
the study will be conducted one month apart.  If you decide to participate, you will be one of 116 
participants in the study.   
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Risks and Benefits of Participation: 
The risks associated with this study are minimal.  It is possible that you may become distressed or 
embarrassed when divulging personal information about your sexual practices on the electronic 
survey.  You may feel uncomfortable due to the sensitive, possibly stigmatizing nature of the 
information you are providing and view the procedure as a violation of your privacy.  However, 
this distress is expected to be minimal and short-lasting.  The groups will include no more 8 
participants.  All participants will be reminded of the importance of keeping any participant 
information confidential.   
 
All data in Part 1 will be conducted in the UNCC psychology computer lab on computers that are 
spaced at least 3 feet apart to ensure privacy or on private computers.  Data collection for Part 2 
of the study will be completed from your own personal computer or a computer of your choice.  
Data will be completed through SurveyShare® and will be protected with SSL encryption.  The 
completed data will then be transferred and stored in a password-protected folder on a password 
protected network drive accessible by only the principal investigator, Dr. Rick McAnulty, Anam 
Barakzai, and the three additional faculty members listed under the current IRB protocol.  Only 
the principal investigator and those listed under the current IRB protocol will have access to the 
data in order to analyze data for completion of dissertation and future manuscripts.   
 
Your data will be linked by time points through the use of a unique identifier.  This identifier will 
consist of the first three letters of their middle name, the first three letters of their birth city, and 
the first three letters of their mother's maiden name, resulting in a 9-letter code.  You will be 
asked to provide this identifier on SurveyShare® each time you complete the surveys.  Your 
name will never be associated with their identifier and will remain unknown to the principal 
investigator. 
 
You will be asked to report any adverse events to either Jocelyn Sweeney or Dr. Rick McAnulty.  
Any indication of emotional distress as a result of the study will be immediately referred to the 
UNC Charlotte Counseling Center or other appropriate mental health services.  Additionally, you 
will be reminded that they are able to drop out of the study at any time. There may be additional 
risks that are currently unforeseeable.   
 
The benefits of participation in this study are the accumulation of 2 Research Requirement points 
at completion of Part 1 and 1 point at completion of Part 2, totaling 3 points towards the Research 
Requirement points for UNCC Introductory Psychology.  Additionally, upon completion of Part 2 
of the study, you will be entered into a drawing for a chance to receive one of ten $50 Target gift 
certificates, resulting in a one in twelve chance of receiving a gift certificate.    
 
By participating in this study, you are furthering the understanding of ways to reduce the risk of 
certain sexually transmitted infections (STIs).  By gaining a better understanding of methods of 
risk reduction and prevention, healthcare providers and educators can be more effective in their 
efforts to intercede and prevent infection with certain STIs, or, if already infected, prevent more 
negative consequences from occurring. 
 
Email Contact 
It is important that you check your campus email while participating in this study.  You will 
receive three emails from Jocelyn Sweeney.  You will receive the first email 21 days after 
completing Part 1 of this study.  This email will serve as a reminder for Part2.  You will receive 
the second email 28 days after completing Part 1.  This email will contain the information you 
need to complete Part 2.  You will also receive a third email after you complete Part 2.  This 
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email will serve to thank you for your participation in the study and will also provide contact 
information for the UNCC Counseling Center, the UNCC Student Health Center, the UNCC 
Research Compliance Office, Jocelyn Sweeney, and Dr. Rick McAnulty.  If you are the winner of 
a gift card, you will also receive a fourth email from Jocelyn Sweeney providing instructions on 
how to claim your gift card. 
 
Volunteer Statement: 
You are a volunteer. The decision to participate in this study is completely up to you. If you 
decide to be in the study, you may stop at any time. You will not be treated any differently if you 
decide not to participate or if you stop once you have started.  
 
Confidentiality: 
Any information about your participation, including your identity, is confidential. The following 
steps will be taken to ensure this confidentiality: 
You will provide data using computer-based surveys using a unique code known only to you.  
With the use of the code, the data will remain anonymous to everyone except you.  The surveys 
are encrypted using SSL.   Data will be stored in a password-protected folder on a password-
protected network drive accessible by only the principal investigator, Dr. Rick McAnulty, 
Anam Barakzai and the three additional faculty members listed under the current IRB protocol.  
Signed informed consent forms will be kept in a locked file cabinet and will be stored 
completely separate and apart from any data.   These documents will be shredded upon 
completion of the study.   
Data will be linked using a unique identifier that will never be associated with your name, 
therefore, the data you provide will be anonymous.  Your identifier will be known only to you.  
No one else, including the researchers, will know your code.   
 
Fair Treatment and Respect: 
UNC Charlotte wants to make sure that you are treated in a fair and respectful manner. Contact 
the University’s Research Compliance Office (704.687.3309) if you have any questions about 
how you are treated as a study participant. If you have any questions about the project, please 
contact Jocelyn Sweeney (jbrinema@uncc.edu) or Dr. Rick McAnulty (704.687.4783 or 
rdmcanul@uncc.edu).   
 
Participant Consent 
I have read the information in this consent form. I have had the chance to ask questions about this 
study, and those questions have been answered to my satisfaction. I am at least 18 years of age, 
and I agree to participate in this research project. I understand that I will receive a copy of this 
form after it has been signed by me and the Principal Investigator.  
 
_______________________________   _____________________________    ________ 
Participant Name (PRINT)    Participant Signature                         DATE 
 
______________________________________      _____________________ 
Investigator Signature DATE 
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APPENDIX G:  INTERVENTION POWER POINT SLIDES 
 
 
  
  
  
Let’s talk about it
1
HPV stands for human papillomavirus
There are over 100 types of HPV
• Infect different areas of the body
We’re going to talk about genital HPV
2
There are 40 types of genital HPV
• Genital HPV is the most common sexually 
transmitted infection (STI)
• The 40 types can infect the cervix, vagina, vulva, 
anus, rectum, and penis
 Types 6 & 11, 16 & 18 are known as ‘high risk’ types
 Meaning – they are the top runners of types that are more 
likely to result in long-term, serious outcomes
3
 No current treatment for HPV available 
• Only treatment for certain effects of the infection
 90% of cases the body’s immune system will fight off 
the infection
 When not fought off by immune system, can have 
serious consequences
• Genital warts
 Caused by Types 6 & 11
• Cancer 
 Caused mainly by Types 16 & 18
 Cervix
 Vulva
 Vagina
 Anus
 Neck
 Penis
4
6.2 million infected with HPV every year
• 4.6 million new infections per year in 15-24 
15% US currently infected with HPV
• 9.2 million 15-24 currently infected
• 43% college women
 Lots of available partners
 Many practice ‘serial monogamy’
 Multiple, brief committed relationships 
50% chance of getting HPV in lifetime
5
Cervical Cancer
• Most common cancer among women
 11,000 women diagnosed every year
• 4,000 deaths per year
Genital Warts
• 1% sexually active adults currently infected
Vulvar Cancer
• 3,460 women diagnosed annually
Vaginal and other genital cancers
• 2,210 women diagnosed annually
Anal Cancer
• 3,050 women diagnosed annually
6
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7
HPV is transmitted through genital 
contact
• so…if you’ve ever had anal, oral, and/or vaginal 
sex then
 YES - you are at risk
 There are certain things that can place you at an even higher 
risk of becoming infected with HPV
8
Factors that increase your risk of infection 
are…
• Multiple sex partners
 Increasing likelihood of being exposed
• Anal, oral, or vaginal sex without protective barriers 
 Aka – condoms, female condoms, dental dam, etc.
• Sex with someone who has had a lot of sex partners
 More likely to carry the infection
• Sex at early age
 Earlier exposure to the infection
9
 Factors that increase the risk of the infection 
becoming more serious (e.g., cervical cancer)
• Infrequent STI testing
 Not being aware of infection so symptoms (e.g., abnormal 
cells) can be treated
• Infrequent or lack of Pap smear
 Same thing here
• Lack of knowledge about HPV
 Don’t know how to prevent infection or what to do when 
infected
• Cigarette use
 Impacts body’s ability to fight off the infection
• History of STI’s
 Again, body’s ability to fight off infection is reduced
10
11
Limit the number of sex partners
Engage in non-penetrative sexual acts
Be more informed about HPV
Get annual Pap smears
Get Regular STI testing
Get the HPV vaccine
• Protects against Types 6, 11, 16 & 18
 Will not protect you if you are already infected with 
that type
 Will protect you against any of the other 4 types that 
you’re not infected with
12
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Talk with partners about their sexual 
history
• Including their STI testing behaviors
Use barrier contraceptives
• Condoms don’t totally protect but they do help
• Other methods are useful too
 Dental dams for oral sex
 Female condoms
• Discuss use of barriers with potential partners to 
increase likelihood that you’ll use them when the 
time comes
13
Use condoms and other barrier 
contraceptives
• Condoms reduce re-infection and speed of 
recovery from infection
• Plus – you’ll reduce the likelihood of passing on 
to your partner
Vaccine still protects against types not 
infected with
• VERY unlikely infected with all types
14
15
Minimal, if any, symptoms
• Most do not know they are infected
• Genital warts 
 This is really the only observable symptom of HPV
 Caused by a specific type
Detected through 
• Pap smear
 Detects cervical abnormalities (abnormal cells)
 IF the Pap smear is abnormal
 They will then test specifically for presence of HPV
 May have to run more tests to determine severity of infection
16
 If Pap smear detects abnormalities
• Cryosurgery to freeze off lesions
• LEEP to remove lesions with hot wire loop
 If warts are present
• Frozen off
• Surgically removed
• Topical medication
17
But do I really have to…
18
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Some say that they are
• Inconvenient
• Uncomfortable
• Embarrassing to buy
 And to bring up to sex partner
Still…the majority of college students 
report that they use a condom most of the 
time or always when having sex
19
Yes, getting a Pap smear can be 
uncomfortable – both physically and 
emotionally
• But the doctor will do everything to make you as 
comfortable as possible
• And hey…all women have to do it!
Vaccines can be uncomfortable too
• Many people worry about the cost 
• Or they just don’t know where to go
20
Normal to feel overwhelmed about this 
process
• Especially if you have to engage in a number of 
changes
• Hard to start something that seems 
embarrassing or overwhelming
Can overcome this embarrassment and 
belief that you’re not capable by 
PLANNING AND PRACTICING!
21
 I’ll reduce the risk of getting infected or 
re-infected
 I won’t infect others
 I won’t have to go to the doctor any more 
than regular visits
 I won’t have to have any additional 
treatments
 I’ll significantly reduce my chances of a 
severe infection (such as cancer) 
developing
22
But where do I start and how do I 
do it?
23
Discuss the use of contraceptives with 
your partner prior to getting in an 
intimate situation
• If you want, just rely on the facts
 They don’t know if they are infected…neither do you
 Best to be safe
• What if they still say no?
 That is a hard situation…
 Continue to discuss with them.  Do not give up
 If  your health is important to you, this is non-negotiable!
24
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Talk with your partners about their sexual 
past
• Yes…this can be hard…especially if you are nervous 
about the answer!
 Remember, this is to protect  yourself.
 In order to protect your sexual health, you must be informed
 This means knowing about your partners past – it’s important to 
know their history of STIs so you can make an informed decision 
regarding your own sexual health
As a responsible partner, you should 
disclose your past also 
• Allowing them to make an informed decision about 
their health
25
 Pap Smears
• Where do I go?
 Call the Student Health Center
 They are ready and willing
 Cost is minimal 
 Call your insurance provider
 They can help you figure out which location is best for you
 STI Testing
• Where do I go?
 Go to your local health department and they will run a full test on 
your FOR FREE!
 HPV Vaccine
• Where do I go?
 Call the Student Health Center and/or call your insurance provider
 They can help you find out which location is best for you
26
Where do I get them?
• Student Health Center – free 
 Just walk up and ask for them
• Health Department - free
• Any local store
 Just put them down and pay for them
 You should feel proud that you’re taking measures to protect 
yourself and act responsibly
How do I use them?
• http://www.teachingsexualhealth.ca/teacher/res
ources/malecondomdemo.html
27
Where do I get them?
• Student Health Center – free 
 Just walk up and ask for them
• Health Department - free
• Many local pharmacies and stores
How do I use them?
• http://www.teachingsexualhealth.ca/teacher/res
ources/femalecondomdemo.html
28
Where do I get them?
• Student Health Center – free 
 Just walk up and ask for them
• Health Department - free
• Make one from a regular condom 
 Just cut the condom down the middle 
How do I use them?
• http://www.teachingsexualhealth.ca/teacher/res
ources/dentaldamdemo.html
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Be sure to get a card from the facilitator after filling out your 
surveys
31
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APPENDIX H:  EMAIL REMINDER SCRIPT 3-WEEKS AFTER PART 1 
 
 
From:  Jocelyn Sweeney 
To: 
CC: 
BCC: student name 
Subject:  Reminder 
Attachments: 
 
Hello!  As was mentioned when you completed the first portion of this study, I am 
writing to remind you that in one week, you will be emailed instructions for completing 
Part 2 of the study, Behaviors, through UNCC SonaSystems®.  As a reminder, your 
participation in this study is voluntary.  Thank you very much for your participation!  
Please contact the principal investigator, Jocelyn Sweeney, with any questions 
(jbrinema@uncc.edu, 980-355-9016).   
 
Sincerely,  
 
Jocelyn Sweeney 
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APPENDIX I:  EMAIL SCRIPT FOR INSTRUCTIONS FOR PART 2 
 
 
From:  Jocelyn Sweeney 
To: 
CC: 
BCC: student name 
Subject:  Code 
Attachments: 
 
Hello!  As was mentioned when you completed the first portion of this study, this email 
is to let you know that it has been 28 days since you participated in the study titled, 
Behaviors Part One. It is time for you to complete Part Two.  In order to do so, you will 
need to log onto UNCC SonaSystems® (http://uncc.sona-systems.com/default.asp), 
search for Behaviors Part Two.  Once you have located the study, you will need to enter 
ZXSLH5MG to gain access to the survey.  As a reminder, your participation in this study 
is voluntary.  Please contact the principal investigator, Jocelyn Sweeney 
(jbrinema@uncc.edu; 980-355-9016) with any questions or concerns.   
 
Sincerely,  
 
Jocelyn Sweeney  
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APPENDIX J:  EMAIL SCRIPT FOR PARTICIPANT THANKS AND CONTACT 
INFORMATION 
 
 
From:  Jocelyn Sweeney 
To: 
CC: 
BCC: student name 
Subject:  Thank you 
Attachments: 
 
Thank you very much for you participation in the study, Behaviors Part 1 & 2.  As 
mentioned in the informed consent, I am providing all participants with contact 
information for the UNCC Counseling Center, Health Center, and IRB, along with my 
information and Dr. Rick McAnulty’s information. Again, this information is being sent 
to all participants in this study.  Thank you again for your participation in this study!   
 
Counseling Center (http://counselingcenter.uncc.edu/) – 704-687-2105 
Student Health Center (http://studenthealth.uncc.edu/) – 704-687-7400 
Research Compliance Office (http://research.uncc.edu/compliance-ethics) – 704-687-
3309 
Jocelyn Sweeney (jbrinema@uncc.edu) – 980-355-9016 
Rick McAnulty, PhD (rdmcanul@uncc.edu) – 704-687-4783 
 
Sincerely,  
 
Jocelyn Sweeney  
